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Abstract
In assessing the efficacy of a time-varying treatment Marginal Structural Models (MSMs) and Structural
Nested Mean Models (SNMMs) are useful in dealing with confounding by variables affected by earlier
treatments. MSMs model the joint effect of treatments on the marginal mean of the potential outcome,
whereas SNMMs model the joint effect of treatments on the mean of the potential outcome conditional on
the treatment and covariate history. These models often consider independent subjects with noninformative
time of observation.
The first two chapters extend the two classes of models to clustered observations with time-varying treatments
in the presence of time-varying confounding. We formulate models with both cluster- and unit-level
treatments and derive semiparametric estimators of parameters in such models. For unit-level treatments, we
consider both the presence and absence of interference, namely the effect of treatment on outcomes in other
units of the same cluster. For MSMs, we show that the use of unit-specific inverse probability weights and
certain working correlation structures can improve the efficiency of estimators under specified conditions.
The properties of the estimators are evaluated through simulations and compared with the conventional GEE
regression method for clustered outcomes. To illustrate our methods, we use data from the treatment arm of a
glaucoma clinical trial to compare the effectiveness of two commonly used ocular hypertension medications.
The third chapter extends SNMMs to situations with intermittent missing observations. In observational
longitudinal studies, subjects often miss prescheduled visits intermittently. Previous literature has mainly
focused on dealing with monotone censoring due to early dropout. Here we focus on intermittent missingness
that can depend on the subjects' covariate and treatment history. We show that under certain assumptions the
standard SNMMs can be used for situations where non-outcome covariates are missing intermittently. In
situations where outcomes are also missing intermittently, we use a method that does not require artificially
censoring the data, but requires a strict missing at random assumption. The estimators are shown to be
consistent and achieve reasonable efficiency. We illustrate the method by estimating the effect of non-steroidal
anti-inflammatory drugs (NSAIDs) on genitourinary pain using data from a study of chronic pelvic pain.
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ABSTRACT
CAUSAL MODELING UNDER COMPLEX DEPENDENCY IN CLUSTERED AND
LONGITUDINAL OBSERVATIONS
Jiwei He
Alisa J. Stephens
In assessing the efficacy of a time-varying treatment Marginal Structural Models (MSMs) and Struc-
tural Nested Mean Models (SNMMs) are useful in dealing with confounding by variables affected by
earlier treatments. MSMs model the joint effect of treatments on the marginal mean of the potential
outcome, whereas SNMMs model the joint effect of treatments on the mean of the potential out-
come conditional on the treatment and covariate history. These models often consider independent
subjects with noninformative time of observation.
The first two chapters extend the two classes of models to clustered observations with time-varying
treatments in the presence of time-varying confounding. We formulate models with both cluster-
and unit-level treatments and derive semiparametric estimators of parameters in such models. For
unit-level treatments, we consider both the presence and absence of interference, namely the effect
of treatment on outcomes in other units of the same cluster. For MSMs, we show that the use of
unit-specific inverse probability weights and certain working correlation structures can improve the
efficiency of estimators under specified conditions. The properties of the estimators are evaluated
through simulations and compared with the conventional GEE regression method for clustered
outcomes. To illustrate our methods, we use data from the treatment arm of a glaucoma clinical
trial to compare the effectiveness of two commonly used ocular hypertension medications.
The third chapter extends SNMMs to situations with intermittent missing observations. In observa-
tional longitudinal studies, subjects often miss prescheduled visits intermittently. Previous literature
has mainly focused on dealing with monotone censoring due to early dropout. Here we focus on in-
termittent missingness that can depend on the subjects’ covariate and treatment history. We show
that under certain assumptions the standard SNMMs can be used for situations where non-outcome
covariates are missing intermittently. In situations where outcomes are also missing intermittently,
we use a method that does not require artificially censoring the data, but requires a strict missing at
iv
random assumption. The estimators are shown to be consistent and achieve reasonable efficiency.
We illustrate the method by estimating the effect of non-steroidal anti-inflammatory drugs (NSAIDs)
on genitourinary pain using data from a study of chronic pelvic pain.
v
TABLE OF CONTENTS
ACKNOWLEDGEMENT . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . iii
ABSTRACT . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . iv
LIST OF TABLES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . ix
LIST OF ILLUSTRATIONS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . x
CHAPTER 1 : INTRODUCTION . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1
1.1 Background . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1
1.2 Novel Developments . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2
CHAPTER 2 : STRUCTURAL NESTED MEAN MODELS TO ESTIMATE THE EFFECTS OF TIME-
VARYING TREATMENTS ON CLUSTERED OUTCOMES . . . . . . . . . . . . . . 4
2.1 Introduction . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 4
2.2 Notation for clustered observations . . . . . . . . . . . . . . . . . . . . . . . . . . . . 5
2.3 Structural models and estimation for point treatments in clustered observations . . . 6
2.4 Structural models and estimation for time-varying treatments in clustered observations 12
2.5 Simulation study . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 16
2.6 Analysis of glaucoma data . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 20
2.7 Discussion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 22
CHAPTER 3 : MARGINAL STRUCTURAL MEAN MODELS TO ESTIMATE THE EFFECTS OF TIME-
VARYING TREATMENTS ON CLUSTERED OUTCOMES . . . . . . . . . . . . . . 26
3.1 Introduction . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 26
3.2 Notation for clustered observations . . . . . . . . . . . . . . . . . . . . . . . . . . . . 27
3.3 Marginal structural models and estimation for a point treatment in clustered observa-
tions . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 28
3.4 Marginal structural models and estimation for time-varying treatments in clustered
observations . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 32
3.5 Simulation study . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 35
vi
3.6 Analysis of glaucoma study . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 40
3.7 Discussion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 42
CHAPTER 4 : ESTIMATION OF STRUCTURAL NESTED MEAN MODELS IN LONGITUDINAL STUD-
IES WITH INTERMITTENT MISSING OBSERVATIONS . . . . . . . . . . . . . . . 46
4.1 Introduction . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 46
4.2 Longitudinal data with intermittent missing observations . . . . . . . . . . . . . . . . 47
4.3 Intermittent missingness in non-outcome covariates . . . . . . . . . . . . . . . . . . 48
4.4 Intermittent missingness in outcomes . . . . . . . . . . . . . . . . . . . . . . . . . . 53
4.5 Analysis of MAPP data . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 57
4.6 Discussion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 60
CHAPTER 5 : DISCUSSION . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 62
5.1 Future directions . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 63
APPENDICES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 66
BIBLIOGRAPHY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 79
vii
LIST OF TABLES
TABLE 2.1 : Small and large sample performance of g-estimators in a simulation
study based on Example 1. DR1 estimator and DR2 estimator are dou-
bly robust, whereas non-DR estimator is not. DR1 uses a flexible working
model for the covariance, whereas DR2 estimator assumes independence
and constant variance over time. AVE EST refers to average estimates, EMP
SE refers to empirical standard error, AVE SE refers to average asymptotic
standard error, and REL
√
MSE refers to square root of mean squared error. 24
TABLE 2.2 : Estimates for variance parameter σ2m and correlation parameter ρm at
each time point for DR1 estimator from Example 1. Sample size N=1000.
σ2m and ρm are estimated by the method of moments approach by Liang and
Zeger (1986). AVE EST refers to average estimates, and EMP SE refers to
empirical standard error. . . . . . . . . . . . . . . . . . . . . . . . . . . . . 25
TABLE 2.3 : Compare the estimators obtained from SNMM and g-estimation to those
from GEE linear regression using two simulation examples. Sample
size N=1000. In Example 1, the association between covariates and poten-
tial outcomes is linear, whereas in Example 2, the association is quadratic.
EMP SE refers to empirical standard error, and
√
MSE refers to square root
of mean squared error. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 25
TABLE 2.4 : Results of glaucoma data analysis. Estimators from doubly robust (DR)
and non-doubly robust (non-DR) approaches are shown. EST refers to esti-
mate, and SE refers to asymptotic standard error. . . . . . . . . . . . . . . 25
TABLE 3.1 : Combination of weights and working correlations required for obtain-
ing consistent estimator under different conditions. . . . . . . . . . . . 35
TABLE 3.2 : Compare estimators obtained from MSM to those from standard GEE
regression. Sample size N=1000. ψ0 represents the intercept, ψ1 rep-
resents the effect of treatment on the same unit, ψ2 represents the effect
of treatment on the opposite unit, ψ3 represents interaction between treat-
ments. The true values of parameters are ψ0 = 0, ψ1 = 2, ψ2 = 1, ψ3 = 0.5.
Independence working correlation was used for between-units and between-
times correlation. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 44
TABLE 3.3 : Compare estimators from MSM with different working correlations for
the example with interference. Sample size N=1000. ψ0 represents the
intercept, ψ1 represents the effect of treatment on the same unit, ψ2 repre-
sents the effect of treatment on the opposite unit, ψ3 represents interaction
between treatments. The true values of parameters are ψ0 = 0, ψ1 = 2, ψ2 =
1, ψ3 = 0.5. The weights used are cluster-specific. The weights used for
AR(1) between times correlation are also time-fixed. . . . . . . . . . . . . . 45
TABLE 3.4 : Compare estimators from MSM with different working correlations for
the example with no interference. Sample size N=1000. ψ0 represents
the intercept, ψ1 represents the effect of treatment on the same unit. The
true values of parameters are ψ0 = 0, ψ1 = 2. Both cluster-specific and
unit-specific weights are used. The weights used for AR(1) between times
correlation are time-fixed. . . . . . . . . . . . . . . . . . . . . . . . . . . . . 45
viii
TABLE 3.5 : Analysis of results from glaucoma study using GEE, MSM with un-
stabilized and stabilized IPW respectively. ψ0 represents the intercept,
ψ1 represents the effect of beta-blocker only on the same unit, ψ2 repre-
sents the difference between prostaglandin analogue and beta blocker on
the same unit, ψ3 represents the difference between combined treatment
and beta blocker on the same unit. The weights used are time-specific and
unit-specific. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 45
TABLE 4.1 : Results for the example with intermittent missingness in non-outcome
covariates. Average estimates (EST), empirical standard errors (SE), av-
erage asymptotic standard errors (ASE) and 95% coverage probability are
listed for the correctly specified treatment as well as the mis-specified treat-
ment model that omits Cm−1. . . . . . . . . . . . . . . . . . . . . . . . . . . 53
TABLE 4.2 : Results for the example with intermittent missingness in covariates
and outcome. Average estimates (EST), empirical standard errors (SE),
average asymptotic standard errors (ASE) and 95% coverage probability are
listed for unweighted estimating equation (No IPW), our approach with un-
stabilized (IPW) or stabilized (Stabilized IPW) weights, monotone censoring
approach with unstabilized (Monotone IPW) or stabilized (Monotone stabi-
lized IPW) weights with K = 5 or K = 7. . . . . . . . . . . . . . . . . . . . . 58
TABLE 4.3 : Results for the example with intermittent missingness in covariates
and outcome, in which if weights are greater than 200, they are trun-
cated at 200. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 58
TABLE 4.4 : Results from analyzing MAPP data . . . . . . . . . . . . . . . . . . . . . . . 60
TABLE B.1 : Compare estimators from MSM with different working correlations for
the example with interference. Sample size N=1000. ψ0 represents the
intercept, ψ1 represents the effect of treatment on the same unit, ψ2 repre-
sents the effect of treatment on the opposite unit, ψ3 represents interaction
between treatments. The true values of parameters are ψ0 = 0, ψ1 = 2, ψ2 =
1, ψ3 = 0.5. The weights used are cluster-specific. The weights used for
AR(1) between times correlation are also time-fixed. . . . . . . . . . . . . . 74
TABLE B.2 : Compare estimators from MSM with different working correlations for
the example with no interference. Sample size N=1000. ψ0 represents
the intercept, ψ1 represents the effect of treatment on the same unit. The
true values of parameters are ψ0 = 0, ψ1 = 2. Both cluster-specific and
unit-specific weights are used. The weights used for AR(1) between times
correlation are time-fixed. . . . . . . . . . . . . . . . . . . . . . . . . . . . . 75
ix
LIST OF ILLUSTRATIONS
FIGURE 2.1 : DAG for an example with single time point . . . . . . . . . . . . . . . . . . 7
FIGURE 2.2 : Partial DAG for an example with time-varying treatments . . . . . . . . . . 12
FIGURE 3.1 : Directed acyclic graph (DAG) for a single time point example. . . . . . . . 28
FIGURE 3.2 : Partial DAG for an example with time-varying treatments. . . . . . . . . . 32
FIGURE 4.1 : Confounding due to missing indicator Scenario 1 . . . . . . . . . . . . . . 50
FIGURE 4.2 : Confounding due to missing indicator Scenario 2 . . . . . . . . . . . . . . 50
FIGURE 4.3 : Selection bias due to missing outcomes . . . . . . . . . . . . . . . . . . . . 54
x
CHAPTER 1
INTRODUCTION
1.1. Background
In assessing the efficacy of a time-varying treatment Marginal Structural Models (MSMs) and Struc-
tural Nested Models (SNMs) are useful in dealing with confounding by variables affected by earlier
treatments. MSMs model the joint effects of treatment on the marginal mean of the potential out-
come. There are two types of SNMs: (1) structural nested mean models (SNMMs) model the joint
effect of treatment on the mean of the outcome conditional on the treatment and covariate history,
and (2) structural nested distribution models (SNDMs) model the joint effect of treatment on the
entire distribution of the outcome conditional on the treatment and covariate history. Compared to
MSMs, SNMs have the advantage of being able to model effect modification by time-varying co-
variates, whereas MSMs can only model effect modification by baseline covariates. SNMs are also
useful for modeling the effect of dynamic treatment regimes, in which the treatment plan changes
according to observed patient characteristics during the treatment course, in contrast to static treat-
ment regimes, in which the entire treatment schedule is known at the time of initiation. Another
advantage of SNMs is that they can work under conditions where certain assumptions fail. For ex-
ample, SNMs may be fit under instrumental variable assumptions when there is unmeasured con-
founding. Despite these advantages of SNMs, MSMs are more widely used compared to SNMs,
partly because the models are easier to understand and can be implemented with standard soft-
ware.
SNMs and MSMs often consider treatment allocation and repeated measures at the individual
level. These models have seldom been used for clustered observations. A common example for
clustered outcomes is eye disease treatment, where two eyes of a given subject form a cluster.
Other examples include infectious diseases among members of the same household etc. Rubin
(1986) calls a situation where “the observation on one unit is unaffected by the particular treatment
assignment to the other units” the “stable unit-treatment value assumption (SUTVA)” [19]. If we
consider each eye as a separate unit for treatment, the SUTVA assumption may be violated. Under
eye-specific treatment, treatment received by one eye may affect outcomes in the other eye of
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the same subject. If the treatments are binary, each eye will have not only two but four possible
treatments, depending on the treatment received by both eyes. VanderWeele (2008) has discussed
SUTVA in the context of neighborhood effects [26]. To our knowledge, the only published work in
this category is from Brumback et al. (2014), where SNMs and an instrumental variable approach
were used to estimate the effect of cluster-level treatment on unit-level outcomes in the presence
of unmeasured confounding [1].
In observational longitudinal studies, subjects are often observed at random times with subject-
specific intervals between consecutive visits. A conventional approach is to convert continuous
time to discrete time points. This will result in intermittent missing observations for many subjects.
In other cases, subjects may miss prescheduled visits intermittently depending on their condition
throughout the study. Most of the previous literature focuses on dealing with monotone censoring.
One approach to analyzing intermittent missing data is to artificially censor the data as mono-
tone and use methods appropriate for monotone data [10]. However, this approach will result in
significant loss of information, especially if many subjects miss an early visit but later return. Time
varying treatments and dynamic observation schedules have been considered with regard to MSMs
by Herna´n et al. (2009) [6]. Most of their work is based on the assumption that treatment changes
only occur at observed times. They used inverse probability weighting to adjust for selection bias
due to the missing outcomes. We consider the implications of dynamic treatment schedules for es-
timating parameters in SNMMs. Like Herna´n et al. (2009), we will focus on the setting of dynamic
observation plan, where a subject’s observation times depend on his treatment and covariate his-
tory.
1.2. Novel Developments
In this dissertation, we develop statistical methods for the design and analysis of longitudinal ob-
servational data with clustered observations or intermittent missing observations. The dissertation
consists of three parts. In Chapter 2, we extend SNMMs to clustered observations with time-varying
confounding and treatments. This is a generalization of Brumback et al. (2014)’s method [1]. We
demonstrate how to formulate models with both cluster- and unit-level treatments and show how
to derive semiparametric estimators of parameters in such models. For unit-level treatments, we
consider interference, namely the effect of treatment on outcomes in other units of the same cluster.
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The properties of the estimators are evaluated through simulations and compared with the conven-
tional GEE regression method for clustered outcomes. To illustrate our methods, we use data from
the treatment arm of a glaucoma clinical trial to compare the effectiveness of two commonly used
ocular hypertension medications.
In Chapter 3, we extend MSMs to clustered observations with time-varying confounding and treat-
ments. Again we demonstrate how to formulate models with both cluster- and unit-level treatments
and show how to derive semiparametric estimators of parameters in such models. We consider
cases where there is presence or absence of interference. We also consider using unit-specific
inverse probability weights (IPWs) and certain working correlation structures to improve the effi-
ciency of estimators under specified conditions. We use the same glaucoma clinical trial data for
illustration and compare the results from the SNMM approach.
In Chapter 4, we extend SNMMs to situations with intermittent missing observations. We show
that under assumptions of last observation carried forward treatment and ignorable treatment the
regular SNMMs can be used for situations where non-outcome covariates are missing intermittently.
We further consider intermittently missing outcomes and use an inverse probability of weighting
approach. Whereas missing data methods often censor subjects after the first missed visit, we
used a method that does not require artificially censoring the data, but requires a stricter MAR
assumption. Results from our simulation studies show that the estimators are consistent and show
some advantage in efficiency in comparison to the monotone censoring approach. To illustrate our
method, we use data from a study of chronic pelvic pain to estimate the effect of non-steroidal
anti-inflammatory drug (NSAIDS) on genitourinary pain.
3
CHAPTER 2
STRUCTURAL NESTED MEAN MODELS TO ESTIMATE THE EFFECTS OF
TIME-VARYING TREATMENTS ON CLUSTERED OUTCOMES
2.1. Introduction
Structural nested models (SNMs) are a class of models that is useful for estimating the causal ef-
fect of a time-varying treatment in the presence of time-varying confounding [12]. In some studies,
treatments are affected by covariates at earlier time points and subsequently affect covariates at
later time points. Confounding that arises in such situations cannot be properly controlled for by
conventional regression methods. However, such problems can be solved by several other meth-
ods, including marginal structural models (MSMs) and SNMs. Compared to MSMs, SNMs have the
advantage of being able to model effect modification by time-varying covariates, whereas MSMs
can only model effect modification by baseline covariates. SNMs are also useful for modeling the
effect of dynamic treatment regimes, in which the treatment plan changes according to observed
patient characteristics during the treatment course, in addition to static treatment regimes, in which
the entire treatment schedule is known at the time of initiation. Another advantage of SNMs is that
they can work under conditions where certain assumptions fail. For example, SNMs may be fit un-
der instrumental variable assumptions when there is no unmeasured confounding. There are two
types of SNMs: (1) structural nested mean models (SNMMs) model the joint effect of treatments
on the mean of the outcome conditional on the treatment and covariate history, and (2) structural
nested distribution models (SNDMs) model the joint effect of treatments on the entire distribution of
the outcome conditional on the treatment and covariate history. So far, SNMs have seldom been
used for clustered observations. Brumback et al. (2014) used SNMs and an instrumental variable
approach to estimate the effect of cluster-level treatment on unit-level outcomes in the presence
of unmeasured confounding [1]. This paper generalizes previous work by formulating SNMMs for
clustered observations with time-varying confounding and treatments. The formulation applies to
both unit-level and cluster-level treatments.
A motivating example is the study of eye disease treatment, where two eyes of a given subject form
a cluster. Eye-specific outcomes from a given subject tend to be correlated, because they share
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subject-specific characteristics. Rubin (1986) calls a situation where “the observation on one unit
is unaffected by the particular treatment assignment to the other units” the “stable unit-treatment
value assumption (SUTVA)” [19]. If we consider each eye as a separate unit for treatment, the
SUTVA assumption may be violated. Under eye-specific treatment, treatment received by one
eye may affect outcomes in the other eye of the same subject. If the treatments are binary, each
eye will have not only two but four possible treatments, depending on the treatment received by
both eyes. VanderWeele (2008) has discussed the SUTVA in the context of neighborhood effects
[26]. In the ophthalmology study, treatments are eye-specific drops. Treatments, clinical covariates,
and outcomes are measured repeatedly over an extended period of time; treatments are therefore
subject to time-dependent confounding. We are interested in modeling the joint effect of a series
of treatments on a series of clustered outcomes. Other examples of clustered observations include
repeated measurements of disease symptoms on the same individual or an infectious disease
among people in the same household.
The structure of the paper is as the following: we first describe the setup for exploring causal effects
among clustered observations. We then formulate SNMMs for clustered observations in a single
time point setting and describe an efficient estimating equation. We then extend the model and
estimation to time-varying treatments and repeatedly measured outcomes. Last, the method is
evaluated using simulation studies and applied to an ophthalmology dataset.
2.2. Notation for clustered observations
We first describe the general structure of data with repeatedly measured treatments and repeatedly
measured clustered outcomes and the definition of a causal effect in such a context. The notation
is based on Robins (1994) with extension for clustered data [12]. Suppose that data is collected on
N clusters, i = 1, 2, ..., N at K + 1 time points, k = 0, 1, ...,K. At each time point k, outcomes are
measured from J units in each cluster, j = 1, 2, ..., J . Let Aimj denote unit-specific treatment in the
jth unit at time m for cluster i, and A†im denote systemic treatment received at time m for cluster i.
Let Lijm denote unit-specific covariates in the jth unit, and L
†
im denote cluster-specific covariates
measured at time m for cluster i. Yimj denotes the observed outcome in jth unit measured at time
m for cluster i. Yimj is considered as part of Limj . Aim = {Aim1, ..., AimJ , A†im} is all treatments
received at time m by cluster i. Lim = {Lim1, ..., LimJ , L†im} is all covariates measured at time m in
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cluster i. Yim = {Yim1, ..., YimJ} is all observed outcomes measured at time m in cluster i. We use
overbars to denote the history of a variable; thus, A¯im = {Ai0,Ai1, ...,Aim} is treatment history
through time m in cluster i, and L¯im = {Li0,Li1, ...,Lim} is covariate history through time m in
cluster i. We use underbars to denote the future of a variable; thus,Yi,m = {Yi,m,Yi,m+1, ...,Yi,K}
is outcomes observed since time m in cluster i. If unstated, the notation in formulation and figures
is for one cluster and therefore omits the subscript i for cluster. The subscript m for time is omitted
in examples with single time point. Unbold Aim, Lim, Yim represent scalar treatment, covariate and
outcome, respectively for subject i at time m in situations without clustered outcomes, which we
use to reference previous literature on SNMMs.
To define causal effects and structural models, we will use potential or counterfactual outcomes
that are outcomes that would be observed were the subject to receive a certain treatment [20]. We
presume that treatments at time m do not affect outcomes prior to time m. Potential outcomes are
considered under a regime, which is defined as a sequential set of treatments a¯K = {a1, ...,aK}.
In formulating SNMs, the regime (a¯m,0), the counterfactual treatment regime that agrees with a¯m
through time m and is 0 thereafter, is of particular interest. Let Ya¯m,0i,k =
{
Y a¯m,0ik1 , ..., Y
a¯m,0
ikJ
}
denote
the potential outcome in cluster i that would be observed at time k where k > m were the cluster
to receive treatment history a¯m through time m and 0 thereafter. Let Y
a¯m,0
i,m+1 = {Ya¯m,0i,m+1, ...,Ya¯m,0i,K }
denote the series of potential outcomes in cluster i that would be observed after time m. Causal
effects can be defined as contrasts of potential outcomes for the same group of subjects under
different treatment regimes. For instance, Ya¯Ki,m −Ya¯
′
K
i,m, where a¯K 6= a¯′K , denotes the causal effect
of treatment a¯K versus a¯′K on a subject’s outcome at time m.
2.3. Structural models and estimation for point treatments in clustered observa-
tions
Prior to describing the formulation of SNMMs for clustered observations, we review the general
concepts of SNMMs for nonclustered outcomes. SNMMs model the contrast between conditional
means of potential outcomes γ∗m(l¯m, a¯m) = g
(
E
(
Y a¯m,0m+1|L¯m = l¯m, A¯m = a¯m
))
−
g
(
E
(
Y
a¯m−1,0
m+1 |L¯m = l¯m, A¯m = a¯m
))
, where g can be any monotone link function. Frequently used
link functions are the identity (g(x) = x), loglinear (g(x) = log(x)), or logistic (g(x) = logit(x)) [12]
[17]. This contrast represents the sequential removal of the effect of a treatment am at time m on
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the means of subsequent potential outcomes after having removed the effect of all later treatments,
a process called “blipping down” [12]. A function γ∗m(l¯m, a¯m) that defines such a contrast is called a
blip function. It can be parameterized with finite dimensional parameter ψ.
We first formulate SNMMs for clustered outcomes in a single time point example, where treatments,
covariates and outcomes are measured at one time point only. In this example, we assume that
each cluster consists of two units, and consider unit-level treatment only. The results can be easily
generalized to situations with more than two units or with cluster-level treatment. A directed acyclic
graph (DAG) is shown in Figure 2.1. The subscript here refers to unit number. L = {L1, L2, L†} is
the set of cluster- and unit-level measured confounder for the effect of joint treatment A = {A1, A2}
on clustered outcomes Y = {Y1, Y2}. We assume that there is no unmeasured confounding be-
tween A and Y. Dashed double arrows represent possible unmeasured confounding within L, A or
Y between units. U and dotted arrows represent possible unmeasured confounding between L and
Y. Let Y aj = Y
aj ,aj′
j denote the potential outcome in jth unit, where aj and aj′ refer to unit-specific
treatment to the same unit and the other within-cluster unit respectively, {j, j′} = {1, 2}, {2, 1}.
L†
L1
L2
A1
A2
Y1
Y2
U
Figure 2.1: DAG for an example with single time point
2.3.1. Structural nested mean models
For binary treatments, we may consider the joint treatment {A1, A2} across units within a cluster as
one combined treatment at the cluster level with 4 levels, namely {0, 0}, {1, 0}, {0, 1}, {1, 1}. Then
a SNMM with joint treatment can be formulated in the same way as one with a single treatment as
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a contrast between means of potential outcomes under joint treatment versus means of potential
outcomes under no treatment as seen in (1). If there is an additional binary systemic treatment A†,
the combined treatment {A†, A1, A2} will contain 8 levels.
E
Y a1,a21
Y a2,a12
∣∣∣ L = l,A = a
− E
Y 0,01
Y 0,02
∣∣∣ L = l,A = a
 =
γ∗1 (a1, a2, l)
γ∗2 (a2, a1, l)
 . (2.1)
The vector-valued blip function γ∗(.) models the effect of removing joint treatment a from both unit-
level outcomes within the cluster. It can be parameterized with the finite dimensional parameter ψ
to form γ∗1(a1, a2, l;ψ)
γ∗2(a2, a1, l;ψ)
 . (2.2)
As an example, let
γ∗1(a1, a2, l;ψ)
γ∗2(a2, a1, l;ψ)
 =
 ψ1a1 + ψ2a2 + ψ3a1 a2
ψ1′a2 + ψ2′a1 + ψ3′a2 a1
 . (2.3)
In (2.3), ψ ∈ R6; ψ1 and ψ1′ represent the effect of unit-specific treatment on the outcome in the
same unit, ψ2 and ψ2′ represent the effect of treatment on the outcome in the opposite unit, ψ3
and ψ3′ represent the interaction between treatments in different units. This example imposes the
assumption that effect modification by covariates is absent.
The dimension of causal parameters will increase sharply with increase in the number of units per
cluster. Some additional model assumptions are considered to reduce the dimension of causal
parameters. For the ophthalmology example, it is reasonable to assume symmetry between two
eyes, namely the effect of the joint treatment is the same for each unit. In (2.3), the symmetry
assumption implies ψ1 = ψ1′ , ψ2 = ψ2′ , ψ3 = ψ3′ . In some cases, we may want to assume no
interference, namely unit-specific treatment on one unit has no effect on outcomes in the other
units of the same cluster. With two units per cluster, it refers to
Y
aj ,aj′
j = Y
aj ,0
j .
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In (2.3), the no interference assumption implies ψ2 = ψ3 = ψ2′ = ψ3′ = 0.
2.3.2. Identifiability
A1-A3 below are sufficient assumptions to identify the causal effect of joint treatment a relative to
no treatment from observed data and therefore the causal parameter ψ.
A1. Consistency. If A = a for a given cluster, then Ya = Y for that cluster.
A2. Conditional exchangeability. Y0,0 ⊥ A|L = l.
A3. Positivity. If fL (l) > 0, then fA|L (a|l) > 0 for all treatments a.
In the presence of interference between units, potential outcomes like Y ajj are not well-defined.
However, under no interference, it is reasonable to relax A1 and define consistency under the
standard assumption for non-clustered data: if Aj = aj for a given unit j, then Y
aj
j = Yj for that
unit. A3 can be relaxed in SNMMs such that the assumption does not need to hold for all L with
fL (l) > 0.
2.3.3. Alternative modeling
An alternative way of modeling the joint effect of {a1, a2} is to use the concepts in SNMMs with
time-varying treatments and sequentially remove the effect of each unit-specific treatment. In the
following example, the effect of treatment on the opposite unit is removed first, followed by the effect
of treatment on the same unit.
1. Remove the effect of treatment on the opposite unit aj′ :
E
(
Y
aj ,aj′
j |L = l,A = a
)
− E
(
Y
aj ,0
j |L = l,A = a
)
= γ∗1,j(aj′ , l, aj) (2.4a)
2. Remove the effect of treatment on the same unit aj :
E
(
Y
aj ,0
j |L = l, Aj = aj
)
− E
(
Y 0,0j |L = l, Aj = aj
)
= γ∗2,j(aj , l) (2.4b)
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For example, the blip functions in (2.4a) and (2.4b) can be parameterized as γ∗1,j(aj′ , l, aj ;ψ) =
ψ2aj′ + ψ3aj′aj and γ∗2,j(aj , l;ψ) = ψ1aj respectively.
Assumptions A1 and A3 plus a sequential ignorability assumption are sufficient to identify the
causal effect in (2.4a) and (2.4b). Specifically, the sequential ignorability assumption states that
Y
aj ,0
j ⊥ Aj′ |L, Aj and Y 0,0j ⊥ Aj |L. Testing for no interference under this model is equivalent to
testing whether the blip function in (2.4a) equals 0. Since the entire covariate history for the clus-
ter is conditioned on in the sequential blipping down, this approach will not cause any additional
collapsibility problem under logit link, if the sequential ignorability assumption holds; otherwise re-
peated averaging over Aj′ is required. However, since aj and aj′ are simultaneous treatments, the
order of blipping down is arbitrary. Parameters from different orders of blipping down have different
interpretations. For this reason, the approach in (2.1) is used for the rest of the paper.
2.3.4. Estimation
Robins (1994) has derived a class of estimating equations for parameters of SNMMs based on
semiparametric theory [12]. He defined Hk(ψ) = Yk −
∑k−1
l=0 γ
∗
l,k
(
L¯l, A¯l;ψ
)
as the fully blipped
down outcome at time k, and H(m) = [Hm+1(ψ), Hm+2(ψ), ....,HK(ψ)]T as the vector of blipped
down outcomes after time m, where m = 0, ...,K−1. Under the sequential ignorability assumption,
E
(
H(m)|L¯m, A¯m
)
= E
(
H(m)|L¯m, A¯m−1
)
. H˙(m) is defined as H˙(m) = H(m) −E (H(m)|L¯m, A¯m−1).
The efficient estimating function, known as the efficient score [25], under general settings involves
complex recursive expressions, but under the assumption that
E
(
HkHj |L¯m, A¯m
)
= E
(
HkHj |L¯m, A¯m−1
)
, (2.5)
for k > m, j > m,m = 0, ...,K − 1, the efficient score can be simplified as:
Seffψ =
N∑
i=1
K−1∑
m=0
[
E
{
∂H˙
(m)
i
∂ψT
∣∣∣ L¯im, A¯im}− E{∂H˙(m)i
∂ψT
∣∣∣ L¯im, A¯i,m−1}] · V ar (H˙(m)i |L¯im, A¯i,m−1)−1 · H˙(m)i
(2.6)
By setting (2.6) to 0 and solving the estimating equation, one can obtain an efficient estimator for
the causal parameter ψ. If the assumption in (2.5) does not hold, the estimator from (2.6) will not
achieve semiparametric efficiency but will nonetheless be consistent. Equivalently, we can express
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(2.6) in terms of the partially blipped down outcome Um with removal of the effect of treatments from
time m onwards [27]. Specifically, Um is a vector with elements Um,k = Yk −
∑k−1
l=m γ
∗
l,k
(
L¯l, A¯l
)
,
for k = m + 1, ...,K. Um mimics the potential outcomes in the sense that E
(
Um |Lm, Am
)
=
E
(
Y
am−1,0
m+1 |Lm, Am
)
. The alternative expression is:
Seffψ =
N∑
i=1
K−1∑
m=0
[
E
{
∂Uim
∂ψT
∣∣∣ L¯im, A¯im}− E{∂Uim
∂ψT
∣∣∣ L¯im, A¯i,m−1}] · V ar (Uim|L¯im, A¯i,m−1))−1 ·
{
Uim − E
(
Uim|L¯im, A¯i,m−1
)}
(2.7)
The theory for SNMMs can be directly applied to situations with clustered observations. We first
construct blipped down outcomes U. For a single time point example with bivariate outcomes, they
can be written as
U =
Y1
Y2
−
γ∗1(A1, A2, L;ψ)
γ∗2(A2, A1, L;ψ)
 .
The following is a parameterized example for blip function under the symmetry assumption:
γ∗1(a1, a2, l;ψ)
γ∗2(a2, a1, l;ψ)
 =
ψ1a1 + ψ2a2 + ψ3a1 a2
ψ1a2 + ψ2a1 + ψ3a2 a1
 (2.8)
Based on (2.7), the efficient score for a single time point example can be written as
Seffψ =
N∑
i=1
{
∂Ui
∂ψT
− E
(
∂Ui
∂ψT
∣∣∣ Li)} · V ar (Ui|Li)−1 · {Ui − E (Ui|Li)} . (2.9)
For the example in (2.8), ∂U
∂ψT
has the following expression:
∂U
∂ψT
=

A1 A2
A2 A1
A1A2 A2A1
 .
E
(
∂U
∂ψT
|L
)
is based on a model for treatment. If treatment probabilities are unknown, a multinomial
logistic regression model can be used to estimate the treatment probability in each category of the
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joint treatment. The estimating equation in (2.9) is doubly robust, because the estimator for ψ will be
consistent if either the model for E
(
∂U
∂ψT
|L
)
or the model for E (U|L) is correctly specified. When
both are correctly specified and the conditional variance V ar (U|L) is also correctly specified, the
estimator achieves the semiparametric efficiency bound for model (2.2) if assumption (2.5) is true.
2.4. Structural models and estimation for time-varying treatments in clustered ob-
servations
We next extend the method to time-varying treatments. Suppose that treatments and covariates
are measured repeatedly at times m = 0, ...,K − 1, and outcomes are measured only at the last
time point K. Figure 2.2 is a partial DAG that shows the effect of a joint treatment from two arbitrary
time points m − 1 and m on the clustered outcomes at time m + 1. The cluster-specific covariate
L†m is omitted from the graph for simplicity. In this example, Lm = {Lm,1, Lm,2} is a time-varying
confounder for the effect of Am = {Am,1, Am,2} on Y = {Y1, Y2}. Therefore, they need to be
controlled for in analysis. Lm, however, also mediates the effect of earlier treatments Am−1 on Y,
which suggests that analysis should not control for Lm. In addition, Lm is a collider on the pathway
from Am−1 to Y. Controlling for Lm will thus induce bias in estimating the causal effect. For these
reasons, conventional regression methods will fail in the presence of time-varying confounding [14].
Lm,1
Lm,2
Am,1
Am,2
Ym+1,1
Ym+1,2
Am−1,1
Am−1,2
U
Figure 2.2: Partial DAG for an example with time-varying treatments
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2.4.1. Structural nested mean models
In the SNMM below, the blip function vector γ∗m(.) models the effect of removing joint treatment am
at time m from both outcomes, after having removed the effect of all subsequent treatments.
E
Y a¯m,01
Y a¯m,02
∣∣∣ L¯m = l¯m, A¯m = a¯m
− E
Y a¯m−1,01
Y
a¯m−1,0
2
∣∣∣ L¯m = l¯m, A¯m = a¯m
 =
γ∗m,1(a¯m, l¯m;ψ)
γ∗m,2(a¯m, l¯m;ψ)
 .
(2.10)
For repeatedly measured outcomes, (2.10) can be further generalized to
E
(
Ya¯m,0m+1 |L¯m = l¯m, A¯m = a¯m
)
− E
(
Y
a¯m−1,0
m+1 |L¯m = l¯m, A¯m = a¯m
)
= γ∗
m
(a¯m, l¯m;ψ), (2.11)
where γ∗
m
is a vector with components γ∗m,k(a¯m, l¯m;ψ) that models the effect of removing joint
treatment at time m from both outcomes at time k, for k = m + 1, ...,K. The sequential ignora-
bility assumption is required to identify the contrast in (2.10) and (2.11). It is a generalization of
assumption A2 to sequential treatments as shown below:
Y
a¯m−1,0
m+1 ⊥ Am|A¯m−1 = a¯m−1, L¯m = l¯m.
A parameterized example for (2.10) is shown below:
γ∗m,1(a¯m, l¯m;ψ)
γ∗m,2(a¯m, l¯m;ψ)
 =
 ψm,1am,1 + ψm,2am,2 + ψm,3am,1 am,2
ψm,1′am,2 + ψm,2′am,1 + ψm,3′am,2 am,1
 . (2.12)
The ψ parameters in (2.12) have similar interpretation as those in example (2.3), except that they
contain subscript m to indicate the effect of joint treatment at time m is time-specific. A more
parsimonious example is shown below:
γ∗m,1(a¯m, l¯m;ψ)
γ∗m,2(a¯m, l¯m;ψ)
 =
ψ1am,1 + ψ2am,2 + ψ3am,1 am,2
ψ1am,2 + ψ2am,1 + ψ3am,2 am,1
 . (2.13)
Model (2.13) makes the symmetry assumption and also assumes the effect of treatments is the
same for each time point. Notice that subscript m is omitted for ψ. The ψ parameters can be
13
interpreted as effect of treatment per unit time.
2.4.2. Estimation
Similar to the single time point case, we first construct a series of partially blipped down outcomes
Um for each time m:
Um =
Y1
Y2
− K−1∑
l=m
γ∗l,1(a¯l, l¯l;ψ)
γ∗l,2(a¯l, l¯l;ψ)
 .
The partially blipped down outcomes mimic the potential outcomes Ya¯m−1,0 in the sense that
E
(
Um|L¯m, A¯m
)
= E
(
Ya¯m−1,0|L¯m, A¯m
)
. For repeatedly measured outcomes, Um is a vector
with components
Um,k =
Yk,1
Yk,2
− k−1∑
l=m
γ∗l,k,1(a¯l, l¯l;ψ)
γ∗l,k,2(a¯l, l¯l;ψ)
 ,
for k = m+ 1, ...,K.
For time-varying treatments, we suggest using the following score:
Sψ =
N∑
i=1
K−1∑
m=0
[
∂γ∗m
(
L¯im, A¯im;ψ
)
∂ψT
− E
{
∂γ∗m
(
L¯im, A¯im;ψ
)
∂ψT
∣∣∣ L¯im, A¯i,m−1}] · V ar (Uim ∣∣∣ L¯im, A¯i,m−1)−1 ·
{
Uim − E
(
Uim|L¯im, A¯i,m−1
)}
. (2.14)
The efficient score in (2.6) is usually too complicated to be used for situations with time-varying
treatments. The estimator from the score in (2.14) is not optimal but is reasonably efficient and dou-
bly robust. It is straightforward to show that the estimator is consistent, if for each time m, either the
model for treatment, E
{
∂γ∗m(L¯m,A¯m;ψ)
∂ψT
∣∣∣ L¯m, A¯m−1}, or the model for outcome, E (Um|L¯m, A¯m−1),
is correctly specified. A simpler non-doubly robust estimating equation is
Sψ =
N∑
i=1
K−1∑
m=0
[
∂γ∗m
(
L¯im, A¯im;ψ
)
∂ψT
− E
{
∂γ∗m
(
L¯im, A¯im;ψ
)
∂ψT
∣∣∣ L¯im, A¯i,m−1}] ·Uim. (2.15)
It does not involve modeling E
(
Um|L¯m, A¯m−1
)
and assumes it to be 0. Therefore, the estimator
from (2.15) is consistent if and only if the model for treatment is correct.
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For the parameterized example in (2.13), we have the following expression for
∂γ∗m(L¯m,A¯m;ψ)
∂ψT
:
∂γ∗m
(
L¯m, A¯m;ψ
)
∂ψT
=

Am,1 Am,2
Am,2 Am,1
Am,1Am,2 Am,2Am,1
 .
Similarly, E
{
∂γ∗m(L¯m,A¯m;ψ)
∂ψT
∣∣∣ L¯m, A¯m−1} is based on a model for treatment. If treatment proba-
bilities are unknown, a multinomial logistic regression model can be used to estimate treatment
probability in each category of the combined treatment {Am,1, Am,2} received at time m. We can
either fit a separate model for each time m, or fit a single model to pooled data from all person
times. For the pooled treatment model, we may allow intercepts to be time-varying with the use of
a spline.
2.4.3. Closed form estimator
If V ar
(
Um|L¯m, A¯m−1
)
is given, and a linear working model Dmδ = dm
(
L¯m, A¯m−1
)
δ is assumed
for E
(
Um|L¯m, A¯m−1
)
, where δ is the q−dimensional nuisance parameter in the outcome model
and dm is a J × q matrix-valued function of
{
L¯m, A¯m−1
}
, and the blip function is linear in ψ with
γ∗m
(
L¯m, A¯m
)
= Rmψ = rm
(
L¯m, A¯m
)
, where ψ is p−dimensional and rm is a J × p matrix-valued
function of
{
L¯m, A¯m
}
, the estimator for ψ will have the following closed form (based on Robins and
Herna´n, 2009):
ψˆ
δˆ
 =

N∑
i=1
K−1∑
m=0
Cim
Dim

T
· V ar
(
Uim
∣∣∣ L¯im, A¯i,m−1)−1 · (∑K−1l=m Ril Dim)

−1
·

N∑
i=1
K−1∑
m=0
Cim
Dim

T
· V ar
(
Uim
∣∣∣ L¯im, A¯i,m−1)−1 ·Yi
 , (2.16)
where Cm =
∑K−1
l=m
[
Rl − E
{
Rl
∣∣ L¯m, A¯m−1}].
A simple working model for V ar
(
Um|L¯m, A¯m−1
)
is σ2IJ×J for some constant variance σ2 at all
times, where IJ×J is an identity matrix of dimension J . However, the independence structure
and constant variance over time are often far from truth. A simulation study described in the next
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section will examine the impact of such mis-specification on the efficiency of ψˆ. If one assumes
a working model other than independence structure and constant variance, estimation will then
require iterative procedures similar to those in generalized estimating equations (GEEs). We can
start by assuming working model σ2IJ×J to obtain an initial estimate for ψ, and then iterate between
estimating parameters in V ar
(
Um
∣∣∣ L¯m, A¯m−1) and estimating ψ until convergence is achieved.
We adapted the method of moments approach by Liang and Zeger (1986) in estimating variance
parameters [9]. An asymptotic variance estimator for ψˆ may be derived using the sandwich method,
with the exact form found in Appendix A.1.
2.5. Simulation study
2.5.1. Algorithm
The data generating process is based on the likelihood for SNMMs described in Robins, Rotnitzky
and Scharfstein (2000) [17]. Details about the likelihood can be found in Appendix A.2. A simulation
study is conducted based on the setting where treatments and covariates are measured repeatedly
at times m = 0, ...,K − 1, and outcomes are measured at the last time point K only. The number
of time points is K = 5, and the cluster size is J = 2. The total number of clusters is varied as
N = 100 or 1000. The algorithm for generating data for one cluster is shown below. It includes
two examples with different covariate effects in the conditional mean of outcomes. Variables with
subscript m = −1 assume value 0.
For m = 0, ...,K − 1, we generated covariates Lm from a multivariate normal distribution:

Lm,1
Lm,2
L†m
 |L¯m−1, A¯m−1 ∼ N3


0.3Lm−1,1 + 0.2Am−1,1
0.3Lm−1,2 + 0.2Am−1,2
0.3Lm−1 + 0.1Am−1,1 + 0.1Am−1,2
 ,

1 0.3 0.2
0.3 1 0.2
0.2 0.2 1

 .
We generated joint treatment Am from a multinomial logistic regression model with probabilities
pm,00, pm,10, pm,01, pm,11:
Am,1
Am,2
 |L¯m, A¯m−1 ∼ multinomial(pm,00, pm,10, pm,01, pm,11),
16
where
pm,10 = mlogit
−1(0.5Lm,1 − 0.5L†m + 0.2Am−1,1),
pm,01 = mlogit
−1(0.5Lm,2 − 0.5L†m + 0.2Am−1,2),
pm,11 = mlogit
−1(0.5Lm,1 + 0.5Lm,2 − L†1 + 0.2Am−1,1 + 0.2Am−1,2),
pm,00 = 1− pm,01 − pm,10 − pm,11.
Last, observed outcomes YK were generated. We first generated the conditional mean of YK
under the sequential ignorability assumption:
E(YK |¯lK−1, a¯K−1) =
K−1∑
m=0
γ∗m(¯lm, a¯m) +
K−1∑
m=1
[
E(Y
am−1,0
K |¯lm, a¯m−1)− E(Yam−1,0K |¯lm−1, a¯m−1)
]
+ E(Y0K |l0).
For both simulation examples,
K−1∑
m=0
γ∗m(¯lm, a¯m) =
K−1∑
m=0
ψ1am,1 + ψ2am,2 + ψ3am,1 am,2 + ψ4am,1 lm,1 + ψ5am,1 l†m
ψ1am,2 + ψ2am,1 + ψ3am,2 am,1 + ψ4am,2 lm,2 + ψ5am,2 l
†
m
 ,
where ψ1 = 2, ψ2 = 0.5, ψ3 = 0.2, ψ4 = 0.5, ψ5 = −0.2, and
E(Y0K |l0) =
2l0,1 − l†0
2l0,2 − l†0
 .
The two examples differ in the association between covariates and the potential outcomes. In
Example 1, the association is linear:
K−1∑
m=1
[
E(Y
am−1,0
K |¯lm, a¯m−1)− E(Yam−1,0K |¯lm−1, a¯m−1)
]
=
K−1∑
m=1

lm,1 − l†m
lm,2 − l†m
− E

lm,1 − l†m
lm,2 − l†m
 |¯lm−1, a¯m−1

 . (2.17)
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In Example 2, the association is quadratic:
K−1∑
m=1
[
E(Y
am−1,0
K |¯lm, a¯m−1)− E(Yam−1,0K |¯lm−1, a¯m−1)
]
=
K−1∑
m=1

(lm,1 − l†m)2
(lm,2 − l†m)2
− E

(lm,1 − l†m)2
(lm,2 − l†m)2
 |¯lm−1, a¯m−1

 . (2.18)
YK was generated from its conditional mean plus a bivariate normal error term:
YK =E(YK |¯lK−1, a¯K−1) + ,
where the error term also follows multivariate normal distribution:
|L¯K−1, A¯K−1 ∼ N2
0,
 1 0.2
0.2 1

 .
2.5.2. Results
Two doubly robust (DR) estimators (2.14) and one without the doubly robust property (2.15) were
computed using the simulated data (Example 1). For both DR estimators, we assume a linear work-
ing model for E
(
Um|L¯m, A¯m−1
)
. For V ar
(
Um
∣∣∣ L¯m, A¯m−1), we either assume an exchangeable
working model Σm = σ2m
 1 ρm
ρm 1
 for each time m and denote the estimator as DR1, or a work-
ing model with independence structure and constant variance Σ = σ2
1 0
0 1
 for all time points
and denote the estimator as DR2. The DR2 estimator has the closed form described in (2.16), but
not the DR1 estimator. The non-DR estimator is based on the score in (2.15).
To estimate treatment probabilities, a multinomial logistic regression model is fit to pooled data
from all time points. Simulation and estimation procedures were repeated for 1000 replicates. The
results are shown in Table 1. Averaged estimates (Ave EST), empirical standard errors (Emp SE),
and averaged asymptotic standard errors (Ave SE) are provided. The square root of mean squared
error (
√
MSE) is computed from Ave EST and Emp SE. All three estimators have negligible bias.
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Coverage of all 95% confidence intervals (CI) at N = 1000 show the expected range of 93%− 96%.
At N = 100, all 95% CIs show under-coverage, likely due to the small sample size. The DR1
estimator has the worst coverage probabilities at N = 100, but it is the most efficient among the
three estimators. The relative
√
MSE of DR2 and non-DR estimators relative to DR1 estimator
ranges from 1.3 − 1.4 and 2.4 − 3.4 respectively. As seen in Table 2, for the DR1 estimator, the
estimates of the variance parameter σ2m and correlation parameter ρm in the conditional variance of
Um decrease over time, since more of the variance is accounted for by the increased treatment and
covariate history in the conditioning. Therefore, a flexible working model for V ar
(
Um
∣∣∣ L¯m, A¯m−1)
used in DR1 estimator tends to improve efficiency.
We did a comparison between g-estimation of SNMMs and standard GEE regression, a conven-
tional method to deal with clustered outcomes. We considered two simulation examples with differ-
ent covariate effects as shown in (2.17) and (2.18). Both SNMM and GEE regression approaches
were applied to the simulated data. Predictors in restricted mean models for GEE include all factors
in the blip functions as well as all covariates used in generating the conditional mean of outcomes.
An exchangeable working model is assumed for the correlation structure. The conditional mean
models used in the GEE approach in the two examples are
Yj ∼
K−1∑
m=0
Amj +
K−1∑
m=0
Amj′ +
K−1∑
m=0
AmjAmj′ +
K−1∑
m=0
AmjLmj +
K−1∑
m=0
AmjLm +
K−1∑
m=0
Lmj +
K−1∑
m=0
Lm,
and
Yj ∼
K−1∑
m=0
Amj +
K−1∑
m=0
Amj′
K−1∑
m=0
AmjAmj′ +
K−1∑
m=0
AmjLmj +
K−1∑
m=0
AmjLm+
L0j + L0 +
K−1∑
m=1
L2mj +
K−1∑
m=1
L2m +
K−1∑
m=1
Lmj · Lm
respectively. The models included correctly specified predictors, but did not properly control for
time-varying confounding. The coefficients corresponding to treatment and effect modification are
shown in Table 3. As expected, the DR1 estimators from SNMMs and g-estimation are unbiased,
whereas bias is induced in GEE estimators by controlling for covariates affected by earlier treat-
ments. In the first example, the GEE estimators are in fact more efficient than the DR1 estimators.
However, the first two GEE estimators are biased. In the second example, the GEE estimators have
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larger standard errors compared to the DR1 estimators, and all of them are biased.
2.6. Analysis of glaucoma data
The Ocular Hypertension Treatment Study (OHTS) is a multi-center randomized trial designed to
evaluate the safety and efficacy of topical ocular hypertensive medication in delaying or preventing
primary open-angle glaucoma in subjects with elevated intra-ocular pressure (IOP) [7]. In the first
part of the study, a total of 1636 subjects with an IOP between 24 mm and 32 mm in one eye and
between 21 mm and 32 mm in the other eye were randomized to either observation or treatment
with commercially available topical ocular hypertension medication. In the second part of the study,
both the observation arm and the treatment arm received medication. The subjects were followed
up every 6 months up to 7.5 years median time in the first part of the study and up to 13 years
median time in the second part.
We use data from 817 subjects in the treatment arm to illustrate our method. In the treatment
arm, the subjects received several classes of topical ocular hypertension medications, including
beta blockers, prostaglandin analogues, topical carbonic anhydrase inhibitors and alpha 2 agonists.
Sometimes more than one type of medication was prescribed for one eye. We are interested
in comparing the effectiveness of the two most common classes, beta blockers and prostaglandin
analogues in lowering IOP. The treatment is eye-specific drops, and the outcome is IOP in each eye.
Within the treatment arm, different medications were not randomized. At each visit, clinicians made
decisions about the type and dose of medication given to each subject, although dose information
is not available in the data provided. Treatment decisions at each time may be influenced by the
subject’s treatment and covariate history. Therefore, the treatment received by these subjects is
time-varying. The subject’s IOPs at each visit are affected by earlier treatment and IOPs, and in
turn affect later treatment and IOPs. Therefore, they are likely to be time-varying confounders.
We created a categorical treatment variable containing 3 categories: beta blocker only (BB), prostaglandin
analogue only (PROST) and beta blocker plus prostaglandin analogue (BB+PROST). Since almost
all subjects received medication only to one eye at baseline, we did not model baseline treatment
but still included relevant baseline covariates in our analysis. In the follow-up visits, once a subject
received no medication or medications other than a beta blocker and prostaglandin analogue in
one of his eyes, the subsequent person-times were excluded from analysis. Since all remaining
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subjects received a beta blocker at the first follow-up visit, treatment at the first follow-up visit was
also not modeled. In this study, most subjects did not receive different treatments in each eye.
Therefore, we decide not to model the effect of treatment on the opposite eye. For each eye, we
pooled all subject-visits and fit a pooled multinomial logistic model after performing model selection
based on AIC. The resulting treatment model was
mlogit Pr[Atj = a|A¯t−1, L¯t] =α0t + α1At−1,j + α2At−1,j′ + α3IOPt,j + α4IOPt,j′ + α5IOPt−1,j+
α6At−1,j · IOPt−1,j + α7RACE + α8AGE + α9IOP0,j ,
where a = 1 or 2 refers to ‘PROST’ or ‘BB+PROST’ versus the reference category ‘BB’. The signif-
icant predictors include IOP in the current time in each eye, IOP in the previous time in the same
eye, treatment in the previous time in each eye, interaction between IOP and treatment in the pre-
vious time in the same eye, as well as baseline covariates race, age and baseline IOP in the same
eye. The time-varying intercept is modeled by a spline to allow more flexibility. The causal effect is
modeled with a blip function with two parameters
E
(
Y a¯m,0k,j |L¯m = l¯m, A¯m = a¯m
)
− E
(
Y
a¯m−1,0
k,j |L¯m = l¯m, A¯m
)
=γ∗m,k,j(a¯m, l¯m;ψ)
=ψ1I(am,j = 1) + ψ2I(am,j = 2),
where ψ1 represents the effect of ‘Prost’ versus ‘BB’, and ψ2 represents the effect of ‘BB+Prost’
versus ‘BB’. Negative values refer to lowering IOP more and therefore indicate that a treatment
is beneficial relative to ‘BB’. This model makes the symmetry assumption and also assumes the
effect of treatment at each time is the same on each of the later outcomes. Both non-doubly robust
(non-DR) and doubly robust (DR) estimators were computed for ψ, and the results are shown in
Table 2.4.
The DR estimators have smaller standard errors compared to the non-DR estimators. Results from
the DR approach show that ψˆ1 = -0.15 with p-value = 0.22, suggesting the effect of ‘PROST’ is not
significantly different from that of ‘BB’, and ψˆ2 = 0.19 with p-value = 0.047, suggesting the combined
treatment ‘BB+PROST’ is significantly worse than ‘BB’ in lowering IOP. The fact that ψˆ2 is positive is
counterintuitive, since we would expect a combined treatment to work better than any of the single
treatments. One possible explanation for this effect is residual confounding not adjusted for in the
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model.
2.7. Discussion
In this work, we have extended SNMMs to settings with clustered observations and time-varying
confounding. We formulate models that are generalized to both cluster- and unit-level treatments,
with consideration of the effect of interference. We also derive semiparametric estimators of param-
eters in those models. Our simulation study demonstrated that the estimators are consistent and
achieve reasonable efficiency in contrast to those from the conventional GEE regression approach.
We have applied the method to compare the effectiveness of two commonly used topical ocular
hypertension medication in lowering IOP using data from the treatment arm of OHTS. In the glau-
coma study, two eyes of a given subject form a cluster. At each visit, different medications were
not randomized in the treatment arm. Therefore, it is a setting with clustered observations and
time-varying confounding. The effect of prostaglandin relative to beta-blocker is not shown to be
statistically significant. The fact that the effect of the combined treatment is shown to be worse
than that of the single treatments is counterintuitive. One likely explanation is residual confound-
ing in the analysis, since clinicians usually prescribe combined treatment if the single ones do not
work. Some of the residual confounding may also be due to the lack of dose information, which
limits the capacity to fairly compare the three treatment categories. The analysis can potentially be
improved by adjusting for loss to follow-up and exclusion of patients on other medications through
inverse probability weighting (IPW). In this particular dataset, the treatment did not differ between
two eyes in most subjects. Simulation study suggests it is not suitable to model interference under
such situations because of the multicollinearity problem (results not shown). However, the method
introduced can potentially be used to model interference among units within the same cluster when
treatment assignments within the cluster are more variable.
We have demonstrated and implemented our method with continuous outcomes and an identity
link in SNMMs. Our method can potentially be generalized to discrete outcomes and other link
functions. For binary outcomes and the logit link, the causal parameter in SNMMs cannot be
estimated with G-estimation [13]. Vansteelandt and Goetghebeur (2003) proposed the generalized
structural mean model to overcome this limitation [28]. The two-stage model includes a structural
model to model causal effect and a traditional association model to model the mean of observed
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outcome in the treatment arm. They also proposed an estimator that is robust to misspecification of
the nuisance association model. The causal model in their approach can be extended to clustered
observations in a similar way described in our method. Extensions of the association model to
clustered observations will be straightforward.
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Table 2.2: Estimates for variance parameter σ2m and correlation parameter ρm at each time
point for DR1 estimator from Example 1. Sample size N=1000. σ2m and ρm are estimated by the
method of moments approach by Liang and Zeger (1986). AVE EST refers to average estimates,
and EMP SE refers to empirical standard error.
σˆ2m ρˆm
Time (m) AveEST
Emp
SE
Ave
EST
Emp
SE
0 7.76 0.38 0.51 0.03
1 6.06 0.29 0.50 0.03
2 4.37 0.19 0.47 0.03
3 2.69 0.11 0.42 0.03
4 1.03 0.03 0.19 0.03
Table 2.3: Compare the estimators obtained from SNMM and g-estimation to those from
GEE linear regression using two simulation examples. Sample size N=1000. In Example 1,
the association between covariates and potential outcomes is linear, whereas in Example 2, the
association is quadratic. EMP SE refers to empirical standard error, and
√
MSE refers to square
root of mean squared error.
DR1 estimator GEE estimator
Example Param True Bias EmpSE Bias
Emp
SE
REL√
MSE
1
ψ1 2.0 -0.00 0.05 -0.08 0.03 1.69
ψ2 0.5 -0.00 0.05 0.08 0.03 1.71
ψ3 0.2 0.00 0.07 0.00 0.04 0.61
ψ4 0.5 0.00 0.03 0.00 0.02 0.56
ψ5 -0.2 -0.00 0.03 0.00 0.02 0.62
2
ψ1 2.0 -0.00 0.06 -0.17 0.10 3.07
ψ2 0.5 -0.00 0.07 -0.02 0.09 1.46
ψ3 0.2 0.00 0.09 0.07 0.13 1.58
ψ4 0.5 0.00 0.04 0.14 0.06 3.56
ψ5 -0.2 0.00 0.04 -0.31 0.06 7.25
Table 2.4: Results of glaucoma data analysis. Estimators from doubly robust (DR) and non-
doubly robust (non-DR) approaches are shown. EST refers to estimate, and SE refers to asymptotic
standard error.
Non-DR estimator DR estimator
EST SE P-Value EST SE P-Value
ψ1 -0.27 0.34 0.21 -0.15 0.20 0.22
ψ2 0.26 0.23 0.12 0.19 0.12 0.05
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CHAPTER 3
MARGINAL STRUCTURAL MEAN MODELS TO ESTIMATE THE EFFECTS OF
TIME-VARYING TREATMENTS ON CLUSTERED OUTCOMES
3.1. Introduction
Marginal structural models (MSMs) are a class of causal models useful for estimating the effect
of time-varying treatments in the presence of time-varying confounding [15]. An MSM is structural
because it is a model for counterfactual outcomes, defined as outcomes that would be observed
were the subject to receive a certain treatment [20]. It is marginal because it describes the effect of
pre-specified treatment regimes on the marginal distribution of their corresponding counterfactual
outcomes. The parameters of an MSM can be consistently estimated by the use of inverse proba-
bility weights (IPW) that create a pseudo-population in which the distribution of confounders is the
same in the treated and the untreated. Therefore, the pseudo-population is free from confounding.
Structural nested models (SNMs) are another major class of causal models that can be used to
deal with time-varying confounding. MSMs are more widely used than SNMs, partly because the
models are easier to understand and can be implemented with standard software. However, both
methods have their respective advantages. Brumback et al. (2014) and He and Marshall (2014)
introduced SNMs for clustered observations [1] [3]. This paper focuses on formulating MSMs for
clustered observations.
A motivating example of eye disease treatment was introduced by Heitjan and Sharma (1997), He
and Joffe (2014), where two eyes of a given subject form a cluster [4] [3]. Eye-specific outcomes
from a given subject tend to be correlated because they share subject-specific characteristics.
Rubin (1986) calls a situation where “the observation on one unit is unaffected by the particular
treatment assignment to the other units the “stable unit-treatment value assumption (SUTVA)” [19].
If we consider each eye as a separate unit for treatment, the SUTVA assumption may be violated.
Under eye-specific treatment, treatment received by one eye may affect the outcome in the other
eye of the same subject. If the treatments are binary, each eye will have not only two but four
potential outcomes, depending on the treatment received by both eyes. In the ophthalmology study,
treatments are eye-specific drops. Treatments, covariates and outcomes are measured repeatedly
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over an extended period of time. We are interested in modeling the joint effect of a series of
treatments on a series of clustered outcomes. Other examples of clustered outcomes include
repeated measures of symptoms of a disease on an individual, or infectious disease among people
in the same household, etc.
Herna´n et al. (2002) have described an MSM for repeated measures and used it to estimate the
effect of zidovudine on CD4 count [5]. Their approach resembles the standard GEE regression,
except that each measure within each subject is given a subject-specific and time-specific weight.
The inverse probability weighting creates a pseudo-population which is free from time-varying con-
founding. As a result, parameters from an MSM have a causal interpretation. The same concept
will be used to formulate MSMs for clustered outcomes.
The structure of the paper is as follows: we first describe the setup for exploring causal effects
among clustered observations. We then formulate MSMs for clustered observations in a single time
point setting and describe the IPW estimation procedure. The model and estimation procedure are
then extended to time-varying treatments and repeatedly measured outcomes. Last, the method is
evaluated using simulation studies and applied to an ophthalmology study.
3.2. Notation for clustered observations
We first describe the general structure of data with repeatedly measured treatments and clustered
outcomes and the definition of a causal effect in such a context. The notation is based on Robins
(1994) with extension for clustered data [12]. Suppose that data is collected on N clusters, i =
1, 2, ..., N at K + 1 time points, k = 0, 1, ...,K. At each time point k, outcomes are measured from
J units in each cluster, where j = 1, 2, ..., J . Let Aimj denote unit-specific treatment in the jth
unit at time m for cluster i, and A†im denote systemic treatment received at time m for cluster i.
Let Lijm denote unit-specific covariates in the jth unit, and L
†
im denote cluster-specific covariates
measured at time m for cluster i. Yimj denotes the observed outcome in the jth unit measured
at time m for cluster i. Past outcomes are considerd covariates for later outcomes such that Yimj
is considered as part of Limj . Aim = {Aim1, ..., AimJ , A†im} is all treatments received at time m
by cluster i, including unit-level and cluster-level treatments. Lim = {Lim1, ..., LimJ , L†im} is all
covariates measured at time m in cluster i. Yim = {Yim1, ..., YimJ} is all observed outcomes
measured at time m in cluster i. We use overbars to denote the history of a variable; thus, A¯im =
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{Ai0,Ai1, ...,Aim} is treatment history through time m in cluster i, and L¯im = {Li0,Li1, ...,Lim} is
covariate history through time m in cluster i. We use underbars to denote the future of a variable;
thus, Yi,m = {Yi,m,Yi,m+1, ...,Yi,K} is outcomes observed since time m in cluster i. If unstated,
the notation in formulation and figures is for one cluster and therefore omits the subscript i for
cluster. The subscript m for time is omitted in examples with a single time point.
We presume that treatments at time m do not affect outcomes prior to time m + 1. Potential
outcomes are considered under a regime, which is defined as a sequential set of treatments
a¯K = {a1, ...,aK}. Let Ya¯mi,m+1 denote the potential outcomes in cluster i that would be observed at
time m+ 1 were the subject to receive treatment history a¯m through time m. Causal effects can be
defined as contrasts of potential outcomes for the same group of subjects under different treatment
regimes. For instance, Ya¯Ki,m − Ya¯
′
K
i,m, where a¯K 6= a¯′K , denotes the causal effect of treatment a¯K
versus a¯′K on a subject’s outcome at time m.
Figure 3.1: Directed acyclic graph (DAG) for a single time point example.
L†
L1
L2
A1
A2
Y1
Y2
U
3.3. Marginal structural models and estimation for a point treatment in clustered
observations
We first consider a single time point example. A directed acyclic graph (DAG) is shown in Figure
3.1. The subscript here refers to unit number. L = {L1, L2, L†} is the set of cluster- and unit-
level measured confounder for the effect of joint treatment A = {A1, A2} on clustered outcomes
Y = {Y1, Y2}. We assume that there is no unmeasured confounding between A and Y. Dashed
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double arrows represent possible unmeasured confounding within L, A or Y between units. U and
dotted arrows represent possible unmeasured confounding between L and Y. Let Y aj = Y
aj ,aj′
j
denote the potential outcome in the jth unit, where aj and aj′ refer to unit-specific treatment to the
same unit and the other within-cluster unit respectively, {j, j′} = {1, 2}, {2, 1}.
3.3.1. Marginal structural models
Marginal structural mean models, a common subclass of MSMs, parameterize the mean of potential
outcomes. Suppose we model the mean of potential outcome in unit j of a cluster as
E
(
Y
aj ,aj′
j
)
= µj (aj , aj′ ;ψ) , (3.1a)
where µj is a known function, and ψ is the parameter to be estimated. A parameterized example is
shown in (3.1b):
µj (aj , aj′ ;ψ) = ψ0 + ψ1aj + ψ2aj′ + ψ3aj aj′ . (3.1b)
The effect of joint treatment {aj , aj′} on the marginal mean of a counterfactual outcome in unit j is
E
(
Y
aj ,aj′
j
)
− E
(
Y 0,0j
)
. Under model (3.1b), this contrast may be represented as ψ1aj + ψ2aj′ +
ψ3aj aj′ , where ψ1 represents the effect of treatment in the same unit, ψ2 represents the effect
of treatment in the other unit, and ψ3 represents the interaction between treatments. Generally
speaking, MSMs can include effect modification by V0, a subset of the baseline covariates L0, as
shown in (3.2). V0 may include cluster-specific and unit-specific covariates such that
E
(
Y
aj ,aj′
j |V0
)
= µj (aj , aj′ ,V0;ψ) . (3.2)
We consider some additional model assumptions. They are not required for identification, but
help simplify the model. For the ophthalmology example, it is reasonable to make a symmetry
assumption, namely under the same joint treatment the potential outcome in each eye is the same
given that the treatment free potential outcome in each eye is the same. In terms of MSMs in (3.1a),
it refers to
µ1 (a1, a2;ψ) = µ2 (a1, a2;ψ) .
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In some cases, we may want to assume no interference, namely unit-specific treatment on one unit
has no effect on outcomes in the other units of the same cluster. With two units per cluster, it refers
to
Y
aj ,aj′
j = Y
aj ,0
j .
For the example in (3.1b), testing this assumption is equivalent to testing ψ2 = ψ3 = 0.
3.3.2. Identifiability
A1-A3 below are sufficient assumptions to identify the MSM in (3.1a, 3.1b) from observed data and
therefore the causal parameter ψ.
A1. Consistency. If A = a for a given cluster, then Ya = Y for that cluster.
A2. Conditional exchangeability. Ya ⊥ A|L = l for all a.
A3. Positivity. If fL (l) 6= 0, then fA|L (a|l) > 0 for all a.
In the presence of interference between units, potential outcomes like Y ajj are not well-defined.
However, under no interference, it is reasonable to relax A1 and define consistency as: if Aj = aj
for a given unit j, then Y ajj = Yj for that unit.
3.3.3. Estimation
Like standard GEE regression, in addition to a mean model, a working model needs to be proposed
for the correlation in the marginal distribution of potential outcomes. For a single time point example,
there is between unit correlation only. For repeated measures of clustered outcomes, there are
both between units and between times correlations. A convenient choice is working independence
correlation. One may also consider applying exchangeable working correlation between units within
a cluster, and AR(1) working correlation between times within a unit for repeated measures.
When the three identifiability assumptions hold, an IPTW method creates a pseudo-population in
which (i) the marginal distribution of potential outcomes is the same as that in the actual population
but (ii) the treatment probabilities at each time depend at most on past treatment history, i.e. in
Figure 3.1 all arrows from covariates L to A are removed [15]. A consistent estimator for ψ can
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be obtained by solving estimating equation (3.3), which is in the form of a weighted GEE with
cluster-specific scalar weight Wi.
N∑
i=1
∑
a
I(Ai = a) ·Wi ·HiV −1i i(ψ) = 0. (3.3)
Hi = {h1(a), h2(a)} is a random function of a, Vi = Vi(a) is the working covariance matrix,
i(ψ) =
i1(ψ)
i2(ψ)
 =
Yi1 − µ1(a;ψ)
Yi2 − µ2(a;ψ)

is the random error. For each joint treatment a, cluster-specific weight Wi is the inverse of the joint
treatment probability for cluster i:
Wi = P (Ai = a|Li)−1 = f(a|Li)−1.
For binary unit-specific treatments, we may consider the joint treatment as a categorical treatment
with 4 levels. If treatment probabilities are unknown, a multinomial logistic regression can be used
to estimate the joint treatment probabilities. A proof of consistency for the estimator from (3.3) can
be found in Appendix B.1.1.
Under no interference, one may obtain a consistent estimator using unit-specific instead of cluster-
specific IPWs. The unit-specific weight is the inverse of the treatment probability for unit j in cluster
i:
Wij = P (Aij = aj |Li)−1 = f(aj |Li)−1.
The estimating equation using unit-specific weight can be written as
N∑
i=1
∑
a
I(Ai = a) ·HiW
1
2
i V
−1
i W
1
2
i i(ψ) = 0, (3.4)
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where
Wi =
Wi1 0
0 Wi2
 .
Appendix B.1.2 proves consistency of the estimator under this setting. It also shows that when esti-
mation includes unit-specific weights consistent estimation requires independence working correla-
tion between units. In longitudinal studies, IPWs from the joint probability of a series of treatments
over time tend to have enormous variation, resulting in significant loss of efficiency in estimators.
The same will occur for joint treatment on outcomes within a cluster, especially when each cluster
contains a large number of units. Therefore, use of unit-specific weights under a condition with no
interference may help improve the efficiency of estimators. Standard errors may be calculated using
the robust variance estimator, which can be obtained directly from the output of standard software
such as geeglm() in R or PROC GENMOD in SAS.
3.4. Marginal structural models and estimation for time-varying treatments in clus-
tered observations
Figure 3.2: Partial DAG for an example with time-varying treatments.
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We next extend the method to a setting with time-varying treatments, where conventional regression
methods will fail [14] and MSMs become useful in dealing with time-varying confounding. Figure
3.2 is a partial DAG that shows the effect of a joint treatment from two arbitrary time points m − 1
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and m on the clustered outcomes at time m + 1. The cluster-specific covariate L†m is omitted from
the graph for simplicity.
3.4.1. Marginal structural models
Generalization to time-varying treatments and repeatedly measured outcomes is straightforward.
Suppose we model the mean of the potential outcome in unit j of a cluster measured at time k + 1
as
E
(
Y a¯kk+1,j
)
= µk+1,j (a¯k;ψ) , (3.5a)
where j = 1, 2, k = 0, ...,K − 1. An example is given by (3.5b):
µk+1,j (a¯k;ψ) = ψ0 + ψ1
k∑
m=0
amj + ψ2
k∑
m=0
amj′ + ψ3
k∑
m=0
amjamj′ , (3.5b)
where ψ1 represents the effect of treatment in the same unit per unit time, ψ2 represents the effect
of treatment in the other unit per unit time, and ψ3 represents the interaction between treatments
per unit time. Similarly, an MSM can include effect modification by baseline covariates V0 as shown
in (3.6):
E
(
Y a¯kk+1,j |V0
)
= µk+1,j (a¯k,V0;ψ) . (3.6)
3.4.2. Estimation
A consistent estimator for ψ can be obtained by fitting standard GEE regression, except that all
outcomes within each cluster measured at time k + 1 are given a cluster-specific and time-specific
weight
Wik =
1∏k
m=0 f
(
Aim|A¯i,m−1, L¯im
) , (3.7)
or stabilized weight
SWik =
k∏
m=0
f
(
Aim|A¯i,m−1
)
f
(
Aim|A¯i,m−1, L¯im
) . (3.8)
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The estimating equation can be written as
N∑
i=1
K∑
k=1
∑
a¯k−1
I(A¯i,k−1 = a¯k−1) ·Wik ·HikV −1ik ik(ψ) = 0, (3.9)
where error ik(ψ) is given by
ik(ψ) =
ik1(ψ)
ik2(ψ)
 =
Yik1 − µk1(a¯k−1;ψ)
Yik2 − µk2(a¯k−1;ψ)
 .
Hik = {hk1(a¯k−1), hk2(a¯k−1)} is a J-dimensional vector of function of a¯k−1, and Vik = Vik(a¯k−1) is
a J × J working covariance matrix for multiple units within a common cluster at time k.
Appendix B.1.3 shows proof of the consistency of the estimator from (3.9). The estimator for ψ
is consistent if the model for f
(
Am|A¯m−1, L¯m
)
is correctly specified. If treatment probabilities
are unknown, they need to be estimated from data. For binary unit-specific treatments, we may
consider the joint treatment as a categorical treatment with 4 levels and model its probabilities
f
(
Am|A¯m−1, L¯m
)
by a multinomial logistic regression. We can model f
(
Am|A¯m−1
)
in the numer-
ator of the stabilized weight by another multinomial logistic regression. Robins et al. (2000) strongly
recommend the use of stabilized weights, because they are typically less variable than unstabilized
weights and can reduce the variance of the estimator for ψ [17]. However, the advantage of stabi-
lized weights is only present when the treatment model used in IPWs is not saturated, for instance,
when the treatment model contains continuous predictors .
With repeatedly measured clustered outcomes, we consider both between-units and between-times
correlations. Different combinations of working correlation and weights can be used to obtain a
consistent estimator under different conditions. These combinations are summarized in Table (3.1)
and will be explored in the simulation study. Under no interference, the estimator will be consistent
if independence correlation is used between units and between times together with unit-specific
and time-specific weights (3.10). If there is interference or non-independence correlation is used
between units, cluster-specific weights (3.7) must be used to ensure consistency of the estimator.
As mentioned in Section 3, IPWs from the probability of joint treatment on clustered outcomes
tend to have large variation, especially when each cluster contains many units. Therefore, use of
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Table 3.1: Combination of weights and working correlations required for obtaining consis-
tent estimator under different conditions.
Weights Working correlations
With interference time-specific and cluster-specific (3.7) independence between timestime-fixed and cluster-specific (3.11)
No interference
time-specific and cluster-specific (3.7) independence between times
time-fixed and cluster-specific (3.11)
time-specific and unit-specific (3.10) independence between times and between units
time-fixed and unit-specific (3.12) independence between units
unit-specific weights may help improve efficiency of the estimator under no interference.
Wikj =
1∏k
m=0 f
(
Aimj |A¯i,m−1, L¯im
) . (3.10)
Under interference, if non-independence correlation is used for between times for the same unit,
time-fixed and cluster-specific weights (3.11) must be used. Time-fixed weights are computed from
the joint probability of all treatments received by a cluster through the last time point K.
Wi =
1∏K
m=0 f
(
Aim|A¯i,m−1, L¯im
) , (3.11)
Under no interference, if non-independence correlation is used for between times for the same unit
and independence correlation is used between units, time-fixed and unit-specific weights (3.12) can
be used to obtain consistent estimators.
Wij =
1∏K
m=0 f
(
Aimj |A¯i,m−1, L¯im
) . (3.12)
The estimator will be biased if non-independence correlation between units is used together with
unit-specific weights or non-independence correlation between times is used together with time-
specific weights.
3.5. Simulation study
3.5.1. Data Generating Algorithm
The data generating process is based on the likelihood for MSMs described in Robins, Rotnitzky
and Scharfstein (2000) [17]. Details about the likelihood can be found in Appendix B.2. A simulation
study is conducted based on the setting where treatments and covariates are measured repeatedly
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at times m = 0, ...,K − 1, and outcomes are measured repeatedly at times k = 1, ...,K. The
number of time points is K = 3, and the cluster size is J = 2. Sample size is 1000. Two examples
that differ in the form of the MSM only are tested. In the first example, data are generated under
interference between units of the same cluster, whereas in the second example, data are generated
under no interference. Simulation and estimation procedures are repeated 1000 times to compute
bias, empirical standard errors (SE) and average asymptotic standard errors (ASE). The algorithm
for generating data for one cluster is shown below. Unless otherwise stated, variables with subscript
m = −1 assume value 0.
We first generated the observed outcome at baseline Y0 from a multivariate normal distribution:
Y01
Y02
 |V0 ∼ N2
0,
 1 0.4
0.4 1

 .
For m = 0, ...,K − 1, we generated covariates Vm from a multivariate normal distribution:

Lm,1
Lm,2
L†m
 |L¯m−1, A¯m−1,Ym ∼
N3


0.3Lm−1,1 + 0.2Am−1,1 + 0.2Ym,1
0.3Lm−1,2 + 0.2Am−1,2 + 0.2Ym,2
0.3L†m−1 + 0.1Am−1,1 + 0.1Am−1,2 + 0.1Ym,1 + 0.1Ym,2
 ,

1 0.3 0.2
0.3 1 0.2
0.2 0.2 1

 .
We then generated joint treatment Am = (A1, A2) from a multinomial logistic regression model with
probabilities pm,00, pm,10, pm,01, pm,11:
Am,1
Am,2
 |L¯m, A¯m−1 ∼ multinomial(pm,00, pm,10, pm,01, pm,11)
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where
pm,10 = mlogit
−1(0.5Lm,1 − 0.5L†m + 0.2Am−1,1 + 0.2Ym,1),
pm,01 = mlogit
−1(0.5Lm,2 − 0.5L†m + 0.2Am−1,2 + 0.2Ym,2),
pm,11 = mlogit
−1(0.5Lm,1 + 0.5Lm,2 − L†1 + 0.2Am−1,1 + 0.2Am−1,2 + 0.1Ym,1 + 0.1Ym,2),
pm,00 = 1− pm,01 − pm,10 − pm,11.
For k = 1, ...,K, we generated the conditional mean of Ya¯k under sequential ignorability assump-
tions based on the formula below:
E(Ya¯k |¯lk−1, a¯k−1) =
k−1∑
m=0
[
E(Ya¯k |¯lm, a¯m−1)− E(Ya¯k |¯lm−1, a¯m−1)
]
+ E(Ya¯k |v0)
=
k−1∑
m=0

lm,1 − 0.5 l†m
lm,2 − 0.5 l†m
− E

lm,1 − 0.5 l†m
lm,2 − 0.5 l†m
 |¯lm−1, a¯m−1

+ E(Ya¯k |v0).
For the example with interference, the MSM for E(Ya¯k |v0) was specified asµk,1(a¯k−1;ψ)
µk,2(a¯k−1;ψ)
 =
ψ0 + ψ1∑k−1m=0 am,1 + ψ2∑k−1m=0 am,2 + ψ3∑k−1m=0 am,1am,2
ψ0 + ψ1
∑k−1
m=0 am,2 + ψ2
∑k−1
m=0 am,1 + ψ3
∑k−1
m=0 am,2am,1
 ,
where ψ0 = 0, ψ1 = 2, ψ2 = 1, ψ3 = 0.5. For the example with no interference, the MSM for
E(Ya¯k |v0) was specified asµk,1(a¯k−1,1;ψ)
µk,2(a¯k−1,2;ψ)
 =
ψ0 + ψ1∑k−1m=0 am,1
ψ0 + ψ1
∑k−1
m=0 am,2
 ,
where ψ0 = 0, ψ1 = 2. Last, Ya¯k was generated from its conditional mean plus an error term:
Ya¯k =E(Y
a¯
k |¯lk−1, a¯k−1) + k,
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where the error term also follows the multivariate normal distribution:
k|L¯k−1, A¯k−1 ∼N2
0,
 1 0.4
0.4 1

 .
3.5.2. Results
Using the simulated data from both examples, we did a comparison between MSM and the con-
ventional GEE regression approach for clustered observations. We also explored the impact of
different working correlation structures and IPWs on the consistency and efficiency of estimators.
If unstated, the IPWs used for MSM are inverse of the joint probability of all previous treatments as
shown in (3.7) for cluster-specific weights and (3.10) for unit-specific weights.
We first did a comparison between MSM and GEE regression estimates. For the MSM approach,
we used cluster-specific IPWs as well as unit-specific IPWs with MSMs and treatment models cor-
rectly specified. Results are shown in Table 3.2. Independence working correlation between times
and between units was applied for these results. As expected, bias was induced in GEE estima-
tors in both examples. For the example with interference, MSM estimators were consistent with
cluster-specific weights but were biased with unit-specific weights. For the example with no inter-
ference, MSM estimators were consistent with cluster-specific or unit-specific weights. Estimators
with unit-specific weights were more efficient compared to those with cluster-specific weights, and
estimators using stabilized weights were much more efficient compared to those using unstabilized
weights. The variance estimator performed well, as shown by the agreement of average asymptotic
standard errors and empirical standard errors as well as the 95% coverage probabilities reaching
nominal levels.
We then explored different working correlation structures in the estimating equations, including
exchangeable correlation between units within a cluster at the same time and AR(1) correlation
between times for the same unit. Results are shown in Table 3.3 and 3.4. For the example with in-
terference, only cluster-specific weights were used, since use of unit-specific weights would results
in bias in this setting (Table 3.1). For AR(1) between times, we used the time-fixed weights stated
in (3.11) and (3.12). This follows from Tchetgen et al. (2012), which states that use of time-specific
38
weights with non-independence working correlation between times will result in bias [24]. For the
example with no interference, I used both cluster-specific weights and unit-specific weights. In the
example with interference, MSM estimators from the alternative working correlations are consis-
tent and have similar SEs compared to those from independence working correlation. In fact, the
estimators from independence working correlation and exchangeable working correlation between
units are identical, which can be easily shown by algebra. In the example with no interference,
the estimators from AR(1) between-times working correlation are consistent and have similar stan-
dard errors compared to those from independent working correlation. Estimators from exchange-
able between-units working correlation are consistent with the use of cluster-specific weights but
have small bias with the use of unit-specific weights. The SEs are also similar to those from in-
dependence working correlation. Estimators with unit-specific weights are slightly more efficient
compared those with cluster-specific weights.
In another simulation example shown in Appendix B.3 and Table B.1 and B.2, the association be-
tween cluster-specific covariates L†m and outcomes was made stronger. For the example with
interference, all estimators were consistent and had larger standard errors compared to the previ-
ous example in Table 3.3. The estimators from using AR(1) between-times correlation are slightly
more efficient than the other estimators. For the example with no interference, the estimators with
cluster-specific weights were consistent, and among them the estimators from using between-units
exchangeable correlation were slightly more efficient than the other estimators. The bias in estima-
tors with unit-specific weights and exchangeable between-units correlation is increased compared
to the previous example in Table 3.4. Similarly, estimators with unit-specific weights are slightly
more efficient compared to those with cluster-specific weights.
Therefore, as theory predicted, unit-specific weights can be used together with independence work-
ing correlation between units in situations with no interference and achieve consistency and higher
efficiency compared to cluster-specific weights. If one would like to use non-independence work-
ing correlation between units or between times, the IPWs must not be unit-specific or time-specific
respectively, otherwise the estimators will be biased. In some cases, use of exchangeable correla-
tion between units together with cluster-specific weights or use of AR(1) correlation between times
together with time-fixed weights will improve the efficiency of estimators.
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3.6. Analysis of glaucoma study
The Ocular Hypertension Treatment Study (OHTS) is a multi-center randomized trial designed to
evaluate the safety and efficacy of topical ocular hypertensive medication in delaying or preventing
primary open-angle glaucoma in subjects with elevated intra-ocular pressure (IOP) [7]. In the first
part of of the study, a total of 1636 subjects with an IOP between 24 mm and 32 mm in one eye and
between 21 mm and 32 mm in the other eye were randomized to either observation or treatment
with commercially available topical ocular hypertension medication. In the second part of the study,
both the observation arm and the treatment arm received medication. The subjects were followed
up every 6 months up to 7.5 years median time in the first part of the study and up to 13 years
median time in the second part.
We used data from 817 subjects in the treatment arm to illustrate our method. In the treatment arm,
the subjects received several classes of topical ocular hypertension medications, including a beta
blocker, a prostaglandin analogue, a topical carbonic anhydrase inhibitor, and an alpha 2 agonist.
Sometimes more than one type of medication was prescribed for one eye. We are interested in
comparing the effectiveness of the two most common classes, beta blockers and prostaglandin
analogues. Within the treatment arm, different medications were not randomized. At each visit,
clinicians made decisions about the type and dose of medication given to each subject, which were
influenced by the subject’s treatment and covariate history. Therefore, the treatment received by
these subjects is time-varying and likely subject to time-varying confounding. The subject’s IOPs at
each visit are affected by earlier treatment, and IOPs in turn affect later treatment and IOPs.
We created a categorical treatment variable containing 3 categories: beta blocker only (BB), prostaglandin
analogue only (PROST) and beta blocker plus prostaglandin analogue (BB+PROST). Since almost
all subjects received medication only to one eye at baseline, we did not model baseline treatment
but still included relevant baseline covariates in our analysis. In the follow-up visits, once a subject
received no medication or medications other than a beta blocker or prostaglandin analogue in one
of his eyes, the subsequent person-times were excluded from analysis. Since all remaining sub-
jects received a beta blocker at the first follow-up visit, treatment at the first follow-up visit was also
not modeled. In the treatment arm, most subjects did not receive different treatments in two eyes.
Therefore, we decided not to model the effect of treatment on the opposite eye. For each eye, we
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pooled all subject visits and fit a pooled multinomial logistic model after performing model selection
based on AIC. Then final model was
mlogit Pr[Atj = a|A¯t−1, L¯t] =α0t + α1At−1,j + α2At−1,j′ + α3IOPt,j + α4IOPt,j′ + α5IOPt−1,j+
α6At−1,j · IOPt−1,j + α7RACE + α8AGE + α9IOP0,j ,
where a = 1 or 2 refers to ‘PROST’ or ‘BB+PROST’ versus the reference category ‘BB’, respectively.
Subscript a is omitted from the α coefficients. The significant predictors include IOP in the current
time in each eye, IOP in the previous time in the same eye, treatment in the previous time in each
eye, interaction between IOP and treatment in the previous time in the same eye, as well as baseline
covariates race, age and baseline IOP in the same eye. The time-varying intercept is modeled by
a spline to allow more flexibility. Inverse of the product of the predicted treatment probabilities at all
previous times was used as IPWs (3.10), which were time-specific and unit-specific. In addition, the
estimating equation is also adjusted for censoring due to early dropout. For stabilized IPW, another
pooled multinomial logistic model was fit:
mlogit Pr[Atj = a|A¯t−1] =α0′t + α1′At−1,j + α2′At−1,j′ ,
and weights were calculated as
ˆSW ikj =
∏k
m=0 fˆ
(
Aimj |A¯i,m−1
)∏k
m=0 fˆ
(
Aimj |A¯i,m−1, L¯im
) .
The mean of the potential outcome in unit j of a cluster measured at time k + 1 was modeled as
µk+1,j (a¯k,V0;ψ) = ψ0 + ψ1k + ψ2
k∑
m=0
I(am,j = 1) + ψ3
k∑
m=0
I(am,j = 2),
where ψ0 represents mean IOP at baseline, ψ1 represents the effect of ‘BB’ per unit time, ψ2 repre-
sents the effect of ‘Prost’ versus ‘BB’ per unit time, and ψ3 represents the effect of ‘BB+Prost’ versus
‘BB’ per unit time. Negative values refer to lowering IOP and indicate a treatment is beneficial. This
model makes the symmetry assumption and assumes the effect of treatment at each time is the
same on each of the later outcomes.
The data were analyzed using GEE regression without weights and MSM with unstabilized and
41
stabilized IPW. Independence working correlation was used for these approaches. Table 3.5 shows
the results of this analysis. Since the study did not start using prostaglandin analogue until the
second follow-up, estimators for ψ2 and ψ3 reflect the effect of prostaglandin at the second follow-
up and later. The estimators from MSM with unstabilized IPW have much larger standard errors
compared to the estimators from MSM with stabilized IPW. We focus on results from the MSM with
stabilized IPW. In the MSM with stabilized IPW, the estimator for ψ2 is not significantly different from
0, suggesting the effect of ‘Prost’ is not different from that of ‘BB’. The estimator for ψ3 is -0.05
(p-value = 0.033), suggesting the combined treatment ‘BB+Prost’ is more effective than ‘BB’ only.
The estimator for ψ1 is -0.07 (p-value < 0.0001), suggesting IOP decreased over time under ‘BB’.
In contrast, in the GEE approach, the estimators for ψ2 and ψ3 are not significantly different from 0,
suggesting the effect of both ‘Prost’ and ‘BB+Prost’ are not different from that of ‘BB’.
3.7. Discussion
In this work, we have extended MSMs to settings with clustered observations and time-varying
confounding. We formulate models that are generalized to both cluster- and unit-level treatments,
and derive semiparametric estimators of parameters in those models. Our simulation study demon-
strated that the estimators from the MSM approach with cluster-specific IPWs and independence
working correlation are consistent in contrast to those from the conventional GEE regression ap-
proach. In settings with no interference, use of unit-specific IPWs may improve efficiency of the
estimator; however, independence between-units working correlation must be used together to en-
sure consistency. Use of non-independence between-units or between-times working correlation
may also improve efficiency in certain settings; however, the IPWs must be cluster-specific and
time-fixed, respectively, to ensure consistency of the estimator. We have demonstrated and im-
plemented our method with continuous outcomes and an identity link in MSM. Our method can be
directly applied to discrete outcomes and other link functions.
We have applied the method to compare the effectiveness of two commonly used topical ocular
hypertension medications in lowering IOP using data from the treatment arm of the OHTS. Results
from the analysis suggest that beta-blocker is not significantly different from prostaglandin analogue
in lowering IOP, but the combined beta-blocker and prostaglandin analogue is more effective than
beta-blocker only. The analysis can potentially be improved by adjusting for censoring of patients
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on other medications through IPW. Although there was not enough between-eye variation in treat-
ments in this dataset to estimate the effect of treatment on the opposite eye, the method introduced
can be used to model interference among units within the same cluster. The same data set has
been analyzed using the SNMM approach by He et al. (2014) [3], where the same treatment model
was used. Results from both analyses suggest that the beta blocker and prostaglandin did not
differ in lowering IOP. There is some contradiction in the effect of the combined treatment versus
beta blocker. Results from the MSM approach suggest the combined treatment is more effective,
whereas results from the SNMM approach suggest the combined treatment is worse than beta
blocker only, which is counterintuitive. The contradiction may be explained by the residual con-
founding unadjusted for in the analyses, some of which was due to the lack of dose information, as
well as mis-specification of the treatment model.
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Table 3.3: Compare estimators from MSM with different working correlations for the example
with interference. Sample size N=1000. ψ0 represents the intercept, ψ1 represents the effect of
treatment on the same unit, ψ2 represents the effect of treatment on the opposite unit, ψ3 represents
interaction between treatments. The true values of parameters are ψ0 = 0, ψ1 = 2, ψ2 = 1, ψ3 = 0.5.
The weights used are cluster-specific. The weights used for AR(1) between times correlation are
also time-fixed.
Independent Exchangeablebetween units
AR(1)
between times
Unstabilized Stabilized Unstabilized Stabilized Unstabilized Stabilized
Param Bias SE Bias SE Bias SE Bias SE Bias SE Bias SE
ψ0 -0.01 0.23 -0.00 0.08 -0.01 0.23 -0.00 0.08 -0.00 0.10 -0.00 0.09
ψ1 0.01 0.11 0.01 0.06 0.01 0.11 0.00 0.06 0.00 0.06 0.01 0.06
ψ2 0.00 0.11 0.00 0.06 0.00 0.11 0.00 0.06 0.00 0.07 0.00 0.06
ψ3 -0.00 0.18 -0.00 0.12 -0.00 0.18 -0.00 0.12 -0.00 0.13 -0.00 0.12
Table 3.4: Compare estimators from MSM with different working correlations for the example
with no interference. Sample size N=1000. ψ0 represents the intercept, ψ1 represents the effect
of treatment on the same unit. The true values of parameters are ψ0 = 0, ψ1 = 2. Both cluster-
specific and unit-specific weights are used. The weights used for AR(1) between times correlation
are time-fixed.
Independent Exchangeablebetween units
AR(1)
between times
Unstabilized Stabilized Unstabilized Stabilized Unstabilized Stabilized
Param Bias SE Bias SE Bias SE Bias SE Bias SE Bias SE
Cluster-specific ψ0 -0.01 0.14 -0.00 0.07 -0.01 0.14 -0.00 0.07 -0.00 0.08 -0.00 0.08
ψ1 0.01 0.08 0.00 0.05 0.01 0.07 0.00 0.05 0.00 0.05 0.00 0.05
Unit-specific ψ0 -0.00 0.07 0.01 0.05 0.04 0.08 0.04 0.06 0.00 0.05 0.00 0.06
ψ1 0.00 0.04 -0.00 0.04 -0.03 0.04 -0.03 0.03 0.00 0.04 -0.00 0.04
Table 3.5: Analysis of results from glaucoma study using GEE, MSM with unstabilized and
stabilized IPW respectively. ψ0 represents the intercept, ψ1 represents the effect of beta-blocker
only on the same unit, ψ2 represents the difference between prostaglandin analogue and beta
blocker on the same unit, ψ3 represents the difference between combined treatment and beta
blocker on the same unit. The weights used are time-specific and unit-specific.
GEE IPW† Stabilized IPW
Param EST SE p-value EST SE p-value EST SE p-value
ψ0 18.97 0.10 <.0001 18.25 0.36 <.0001 18.89 0.13 <.0001
ψ1 -0.10 0.01 <.0001 0.02 0.04 0.56 -0.07 0.01 <.0001
ψ2 0.02 0.03 0.62 -0.11 0.07 0.11 -0.07 0.06 0.245
ψ3 0.03 0.02 0.155 -0.06 0.05 0.18 -0.05 0.03 0.033
†: Unstabilized weights are truncated at 2000
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CHAPTER 4
ESTIMATION OF STRUCTURAL NESTED MEAN MODELS IN LONGITUDINAL STUDIES
WITH INTERMITTENT MISSING OBSERVATIONS
4.1. Introduction
In observational data, subjects may miss prescheduled visits intermittently. In other cases, sub-
jects are observed at random times with subject-specific intervals between consecutive visits. A
conventional approach is to convert continuous time to discrete time points. This will also result
in intermittent missing observations. Previous studies have discussed estimation in longitudinal
studies with missing covariates. Robins et al. (1994) proposed a class of semiparametric estima-
tors, based on inverse probability weighted estimating equations, that are consistent when data
are missing at random (MAR) [18]. In particular, they proposed a method to deal with intermittent
missing patterns. Herna´n et al. (2009) discussed the problem of random observation times with
time-varying treatments in the context of marginal structural models (MSMs) [6]. Most of their work
focuses on the setting of dynamic observation plan, where a subject’s observation times depend
on his treatment and covariate history. This paper considers the impact of informative, intermittent
missingness on estimation of structural nested mean models (SNMMs). MSMs model the effect of
treatment on the marginal mean of the potential outcome, whereas SNMMs model the joint effect of
treatments on the mean of the potential outcome conditional on the treatment and covariate history.
We further evaluate the implications of informative intermittent missingness by simulation.
The structure of the paper is as the following: we first describe the setup for exploring causal ef-
fects using longitudinal data with intermittent missing observations. We then consider two settings:
(1) there is intermittent missing non-outcome covariates only and (2) there is intermittent missing
covariates and outcomes. The latter is a more general setting. We formulate SNMMs and derive
consistent estimation procedures for both settings. The methods are evaluated using simulation
studies. Lastly, a dataset from the Multidisciplinary Approach to the Study of Chronic Pelvic Pain
(MAPP) Research Network is used for illustration.
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4.2. Longitudinal data with intermittent missing observations
4.2.1. Notation
We begin with the notation for longitudinal data with intermittent missing observations. Suppose
that data is collected among K + 1 time points, k = 0, 1, ...,K. Let Aim denote the treatment at
time m for subject i. Let Lim denote covariates at time m for subject i. Let Yim denote outcome at
time m for subject i. Yim is part of Lim. An indicator variable Cim = 1 if a subject i is observed at
time m, and Cim = 0 otherwise. Therefore, the complete data at time m for subject i consists of
{Cim, Lim, Aim}. In this paper, we focus on the setting with dynamic observation plan, such that
Cim is a random variable that can depend on the subject’s treatment and covariate history.
We consider (c¯, a¯) as a joint treatment regime, which is the conventional formulation for estimat-
ing causal effects using censored data [15]. Y c¯m,a¯mi,m+1 denotes the potential outcome for subject i
observed at time m + 1 were the subject to receive observation plan c¯m and treatment history a¯m
through time m. The causal effect is defined as a contrast between potential outcomes under dif-
ferent joint treatment regimes. Usually one is interested in the contrast of potential outcomes under
a given observation plan but different treatments, for instance, Y c¯,a¯i − Y c¯,a¯
′
i , where a¯ 6= a¯′.
4.2.2. Structural nested mean models
SNMMs model the contrast between conditional means of potential outcomes. If we consider (c¯, a¯)
as a joint treatment regime, the SNMM has the following general form:
g
(
E
(
Y c¯;a¯m,0k |L¯m = l¯m, C¯m = c¯m, A¯m = a¯m
))
− g
(
E
(
Y
c¯;a¯m−1,0
k |L¯m = l¯m, C¯m = c¯m, A¯m = a¯m
))
=γ∗m,k
(
a¯m, c¯m, l¯m;ψ
)
. (4.1)
This contrast represents the sequential removal of the effect of a treatment am at time m on the
means of subsequent potential outcomes after having removed the effect of all later treatments, a
process called “blipping down” [12]. It can be parameterized with finite dimensional parameter ψ.
We show in following sections the observation plan must be accounted for in estimating SNMM
parameters in some cases, otherwise it will lead to confounding and selection bias.
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4.2.3. Identifiability
The usual identifiability assumptions for SNMMs [12] can be generalized to settings with intermittent
missingness. A1-A3 below are sufficient assumptions to identify the causal effect of joint treatment
(c¯, a¯) from observed data.
A1. Consistency. If C¯ = c¯, A¯ = a¯ for a given subject, then Y c¯,a¯k = Yk for that subject.
A2. Conditional exchangeability. Y c¯,a¯k ⊥ (Cm, Am)|L¯m = l¯m, C¯m−1 = c¯m−1, A¯m−1 = a¯m−1 for
k > m.
A3. Positivity. If f
(
l¯m, c¯m−1, a¯m−1
)
> 0, then f
(
cm, am|l¯m, c¯m−1, a¯m−1
)
> 0.
The positivity assumption can be relaxed in SNMMs, so that it does not need to hold for all
f
(
l¯m, c¯m−1, a¯m−1
)
> 0. As shown in later sections, the setting where there is intermittent miss-
ingness in outcomes requires more stringent conditional exchangeability compared to the setting
where there is intermittent missingness in non-outcome covariates only.
4.3. Intermittent missingness in non-outcome covariates
We first consider a situation where covariates and treatments are observed repeatedly at random
times and the outcome is observed at the last follow-up time K with no missingness.
In some cases, it is reasonable to assume that treatment changes only at observed times, whereas
at unobserved times, treatment assumes the value at the previous time, as stated in (4.2). For in-
stance, a patient may continue to take the same medication until the doctor changes his prescription
at a visit.
Cm = 0⇒ Am = Am−1. (4.2)
Under this assumption, there is no missingness in the treatment variable. The treatments at unob-
served times are deterministic and therefore free of confounding. The observed data for subject i
at time m consists of {Cim, CimLim, Aim}. As stated in Herna´n et al. (2009) [6], assumption (4.2)
may be violated in many cases. For instance, at times with no visit, change in treatment may be
reported by patients in the next visit, but confounder information is missing at those times. It is more
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challenging to obtain consistent estimator under such conditions. This paper focuses on deriving
consistent estimator in the situation where assumption (4.2) holds. In some situations, treatment
assignments only depend on observed covariate and treatment history. For instance, physicians
make treatment decisions based on available information about a particular patient. Under this
assumption, there is no unmeasured confounding to treatment at all person-times, even though
covariates and treatments may be missing at certain times. This ignorable treatment assumption
is stated in assumption (4.3), where the superscript (o) indicates the labeled variable is observed.
Since usually we are not interested in the direct effect of observation plan, it is assumed to be zero
and will not be blipped down in SNMMs, otherwise the ignorability assumption also needs to hold
for the missing indicator Cm.
Y
c¯;a¯m−1,0
k ⊥ Am|L¯(o)m , C¯m, A¯(o)m−1, k > m. (4.3)
4.3.1. Confounding by observation plan
The observation plan can be a confounder in two ways. As illustrated in figure 4.1, if there is
unmeasured confounding between Cm and the outcome Yk, one needs to simultaneously control
for Lm and Cm in order to estimate the effect of treatment on the outcome. In this case, Cm can
be considered as a time-varying covariate just like Lm. Similarly, missing indicators at all previous
times can be a confounder. In the second scenario, if treatment Am depends on the last observed
covariate L∗m−1 by time m−1, the missing indicator Cm−1 can be a confounder even in the absence
of unmeasured confounding between Cm−1 and the outcome. This scenario is illustrated by Figure
4.2 (adapted from Herna´n et al. (2009) [6]): there are arrows from both Lm−1 and Cm−1 to Lm−1∗,
because Lm−1∗ is equal to Lm−1, the covariate measured at timem−1, only if Cm−1 = 1, otherwise
it is equal to some earlier covariate value. Therefore, L∗m is a collider. Conditioning on L∗m will open
pathway from Cm−1 to Yk. Again one needs to simultaneously control for L∗m−1 and Cm−1 in order
to estimate effect of treatment on the outcome.
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Lm
U
Cm Am Yk
Figure 4.1: Confounding due to missing indicator Scenario 1
Cm−1 L∗m−1 Am
Lm−1
U
Yk
Figure 4.2: Confounding due to missing indicator Scenario 2
4.3.2. Structural nested mean models and estimation
If there is no effect modification by past covariates, the SNMM can be written as
g
(
E
(
Y c¯;a¯m,0k |L¯m = l¯m, C¯m = c¯m, A¯m = a¯m
))
− g
(
E
(
Y
c¯;a¯m−1,0
k |L¯m = l¯m, C¯m = c¯m, A¯m = a¯m
))
=γ∗m,k (a¯m, c¯m;ψ) . (4.4)
It models the effect of removing treatment at time m from outcome at time k after having removed
the effect of all later treatments, and is called a blip function. A parameterized example of (4.4) is
shown in (4.5). It includes effect modification by the past observation frequency:
γ∗m,k (a¯m, c¯m;ψ) = ψ1am + ψ2am
(
m−1∑
l=0
cl
)
/m. (4.5)
The observation frequency may reflect the patient’s condition which has an impact on the treatment
effect. Furthermore, if there is no effect modification by past covariates or observation plan, the
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SNMM can be simplified as:
g
(
E
(
Y c¯;a¯m,0k |L¯m = l¯m, C¯m = c¯m, A¯m = a¯m
))
− g
(
E
(
Y
c¯;a¯m−1,0
k |L¯m = l¯m, C¯m = c¯m, A¯m = a¯m
))
=γ∗m,k (a¯m;ψ) . (4.6)
When we consider an example where the outcome is only measured at the last time point K with
no missingness, the subscript k on outcome is omitted. If assumptions (4.2) and (4.3) hold, the
estimating equation (4.7) will give a consistent estimator for the causal parameter ψ in (4.4). The
superscript (o) is omitted from treatment, since assumption (4.2) implies all treatments are known.
(4.7) is the same as the standard SNMM estimating equation, except that treatment may depend
on the observation history. For the parameterized example in (4.5), the estimating equation is spec-
ified as (4.8). When Cim = 1, treatment Aim is deterministic and therefore does not contribute to
the estimating equation. Therefore, although assumption (4.2) violates the usual positivity assump-
tion, it does not cause problem for estimation. Furthermore, assumption (4.2) also implies effect
modification by Cim is not identifiable.
N∑
i=1
K−1∑
m=0
{
∂γ∗m
(
C¯im, A¯im;ψ
)
∂ψ
− E
(
∂γ∗m
(
C¯im, A¯im;ψ
)
∂ψ
∣∣∣ L¯(o)im, C¯im, A¯i,m−1
)}
·{
Yi −
K−1∑
l=m
γ∗l
(
C¯il, A¯il;ψ
)}
= 0. (4.7)
N∑
i=1
K−1∑
m=0
 1(∑m−1
l=0 Cil
)
/m
{Aim − E(Aim|L¯(o)im, C¯im, A¯i,m−1)} ·
{
Yi −
K−1∑
l=m
(
ψ1Ail + ψ2Ail
(
l−1∑
l′=0
Cil′
)
/l
)}
= 0. (4.8)
(4.4) and (4.7) can be easily generalized to include effect modification by baseline covariates, if
baseline variables are observed for all subjects. If the SNMM contains effect modification by time-
varying covariates that are not always observed, the usual g-estimator based on observed data will
be biased.
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4.3.3. Simulation study
Algorithm
We did a simulation study for the setting with no missingness in the outcome but intermittent miss-
ingness in covariates. The data generating process is based on the likelihood for SNMMs described
in Robins, Rotnitzky and Scharfstein (2000) with modification on intermittent missingness [17]. The
details of the likelihood can be found in Appendix C.1. Covariates and treatments were generated
among observation times ∈ (0, 1, ...,K − 1) with intermittent missingness, and outcomes are gen-
erated only at the last follow-up time K with no missingness. The number of time points is K = 5.
Data were simulated for 1000 subjects.
Data were generated under assumptions (4.2) and (4.3) hold. The SNMM is stated in (4.5). Here
is the algorithm for generating data for one subject. For m = 0, we generated the baseline co-
variate from normal distribution L0 ∼ N(0, 1). Under the assumption of no missing baseline visit,
C0 = 1 for all subjects. We then generated the baseline treatment A0|L0 from logistic regres-
sion logit−1(L0). For m = 1, ...,K − 1, we iterated the following steps to generate covariates
and treatment in the follow-up visits. We generated Lm|L¯m−1, C¯m−1, A¯m−1 from the normal dis-
tribution N(0.5Lm−1 + 0.3Am−1, 1). We generated Cm|L¯m, C¯m−1, A¯m−1 from logistic regression
logit−1 (−Lm − 0.5Cm−1 +Am−1). If Cm = 1, we generated Am|L¯(o)m , C¯m, A¯(o)m−1 from logistic re-
gression logit−1 (Lm − 2Cm−1 − 0.5Am−1), else if Cm = 0, we let Am = Am−1. Lastly, we gener-
ated the conditional mean of outcome based on
E(Y |¯lK−1, c¯K−1, a¯K−1) =0 +
K−1∑
m=0
2 · [Lm − (0.5Lm−1 + 0.3Am−1)] +
K−1∑
m=0
1 · [Cm − logit−1(−Lm − 0.5Cm−1 +Am−1)]+
K−1∑
m=0
[
ψ1Am + ψ2Am
(
m−1∑
l=0
Cl
)
/m
]
,
where ψ1 = 1 represents the main treatment effect per unit time, and ψ2 = −1 represents effect
modification by past observation frequency. This formulation is consistent with the ignorable treat-
ment assumption (4.3), but includes unmeasured confounding by the missingness indicators. We
generated the random error |¯lK−1, c¯K−1, a¯K−1 from normal distribution N(0, 1), and then gener-
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ated the observed outcome by Y = E(Y |¯lK−1, c¯K−1, a¯K−1) + .
Results
We applied estimating equation (4.8) to the simulated data. The simulation and estimation proce-
dures were repeated 1000 times to give average estimates (EST), empirical standard errors (SE),
average asymptotic standard errors (ASE) and 95% coverage probability. As shown in Table 4.1, the
estimators from a correctly specified treatment model (correct) are consistent with reasonable effi-
ciency. The average asymptotic standard errors are close to empirical standard errors. Coverage
of 95% confidence intervals roughly agrees with the nominal level. In contrast, the estimators from
a mis-specified treatment model (mis-specified) with confounder Cm−1 being omitted are biased.
Table 4.1: Results for the example with intermittent missingness in non-outcome covari-
ates. Average estimates (EST), empirical standard errors (SE), average asymptotic standard errors
(ASE) and 95% coverage probability are listed for the correctly specified treatment as well as the
mis-specified treatment model that omits Cm−1.
Correct Mis-specified
TRUE EST SE ASE 95%COV EST SE ASE
95%
COV
ψ1 1.00 1.00 0.28 0.27 0.93 1.28 0.37 0.27 0.74
ψ2 -1.00 -1.00 0.77 0.89 0.97 -1.92 1.24 1.37 0.92
4.4. Intermittent missingness in outcomes
4.4.1. Selection bias by observation plan
If the outcome is measured at each visit, both outcomes and time-varying covariates may have
intermittent missingness. Unlike the previous example with no missingness in the outcome, using
regular SNMMs will result in selection bias in this setting, unless observation plan is fixed and
independent of the subject’s history. The selection bias problem is illustrated by Figure 4.3, where
the rectangle around Cm+1 indicates only observed outcomes at time m + 1 (Cm+1 = 1) can be
used in the analysis. Since Cm+1 is the descendant of a collider Lm+1, conditioning on Cm+1 will
cause false association between Am and Ym+1, thereby resulting in bias in the estimator. We use
an inverse probability weighting approach to control for selection bias due to missing outcomes.
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Am
U
Lm+1 Cm+1 Ym+1
Figure 4.3: Selection bias due to missing outcomes
4.4.2. Estimation
One approach to analyzing non-monotone missing data is to artificially censor the data as mono-
tone and use methods appropriate for monotone data [10]. Estimates from the approach can be
interpreted as the treatment effect among a population where subjects have no missingness at
each visit. However, this approach will result in significant loss of information, especially if many
subjects miss an early visit but later return. Robins and Rotnitzky (1995) show that without ad-
ditional assumption about the missing data mechanism, no information about the parameter of
interest can be obtained from the additional visits of subjects who have once missed a visit [16].
Suppose that we impose the following ignorability assumption to the missing indicator:
Y
c¯;a¯m−1,0
k ⊥ Cm|L¯(o)m , C¯m−1, A¯(o)m−1, k > m. (4.9)
Under this assumption, missingness only depends on the past observed data. There will be no
unmeasured confounding to the missingness indicators. However, the confounding scenario in
Figure 4.2 may still occur so that missingness indicator needs to be controlled for. If assumptions
(4.2), (4.3) and (4.9) hold and there is no effect modification by the past covariates, a consistent
estimator for the causal parameter ψ in (4.4) can be obtained from the following inverse probability
weighted estimating equation:
N∑
i=1
K−1∑
m=0
K∑
k=m+1
{
∂γ∗m,k
(
C¯im, A¯im;ψ
)
∂ψ
− E
(
∂γ∗m,k
(
C¯im, A¯im;ψ
)
∂ψ
∣∣∣ L¯(o)im, C¯im, A¯i,m−1
)}
·
{
Yik −
k−1∑
l=m
γ∗l,k
(
C¯il, A¯il;ψ
)} · Cik · k∏
l=m+1
Wil = 0, (4.10)
where
Wil = P
(
Cil|L¯(o)il , C¯i,l−1, A¯i,l−1
)−1
. (4.11)
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Proof of consistency of the estimator is shown in Appendix C.2. A more efficient estimator can be
obtained from an inverse probability weighted estimating equation with stabilized weights:
SWil = P
(
Cil|C¯i,l−1, A¯i,l−1
) · P (Cil|L¯(o)il , C¯i,l−1, A¯i,l−1)−1 . (4.12)
The estimators from (4.10) can be interpreted as treatment effect among a population with the
same distribution of observation plans as in the study population.
For comparison, in the simulation study, we also derive an estimator using the unweighted estimat-
ing equation (4.13), as well as the estimating equation appropriate for monotone data (4.14).
K−1∑
m=0
K∑
k=m+1
{
∂γ∗m,k
(
C¯im, A¯im;ψ
)
∂ψ
− E
(
∂γ∗m,k
(
C¯im, A¯im;ψ
)
∂ψ
∣∣∣ L¯(o)im, C¯im, A¯i,m−1
)}
·
{
Yik −
k−1∑
l=m
γ∗l,k
(
C¯il, A¯il;ψ
)} · Cik = 0. (4.13)
K−1∑
m=0
K∑
k=m+1
{
∂γ∗m,k
(
C¯im, A¯im;ψ
)
∂ψ
− E
(
∂γ∗m,k
(
C¯im, A¯im;ψ
)
∂ψ
∣∣∣ L¯(o)im, C¯im, A¯i,m−1
)}
·
{
Yik −
k−1∑
l=m
γ∗l,k
(
C¯il, A¯il;ψ
)} · k∏
l=1
Cil ·
k∏
l=m+1
W †il = 0, (4.14)
where
W †il = P
(
Cil = 1|L¯(o)il , C¯i,l−1, A¯i,l−1
)−1
. (4.15)
For monotone data, a more efficient estimator can also be obtained from an inverse probability
weighted estimating equation with stabilized weights:
SW †il = P
(
Cil = 1|C¯i,l−1, A¯i,l−1
) · P (Cil = 1|L¯(o)il , C¯i,l−1, A¯i,l−1)−1 . (4.16)
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4.4.3. Simulation study
Algorithm
We did a simulation study for the setting with intermittent missingness in both outcome and covari-
ate. Again the data generating process is based on the likelihood for SNMM described in Robins,
Rotnitzky and Scharfstein (2000) with modification on intermittent missing observations [17]. The
details of the likelihood can be found in Appendix C.1. Covariates and treatments were generated
among times m = 0, 1, ...,K − 1, and outcomes were generated among times k = 1, ..,K with
intermittent missingness. The number of time points is K = 5 or 7. Date were generated for 1000
subjects.
This example assumes assumptions (4.2), (4.3) and (4.9) hold. The SNMM is γ∗m,k (c¯m, a¯m;ψ) =
ψ1am. Here is the algorithm for generating data for one subject. For m = 0, we generated the
baseline covariate L0 ∼ N(0, 1). Under the assumption of no missing baseline visit, C0 = 1 for all
subjects. We then generated the baseline treatment A0|L0 from logistic regression logit−1(L0). For
m = 1, ...,K−1, we iterated the following steps to generate covariates and treatment in the follow-up
visits. We generated Lm|L¯m−1, C¯m−1, A¯m−1 from normal distributionN(0.5Lm−1+0.3Am−1, 1). We
generated Cm|L¯(o)m , C¯m−1, A¯(o)m−1 from logistic regression logit−1
(
0.5− L†m−1 − 0.5Cm−1 +Am−1
)
,
where L†m−1 is the last observed covariate by timem−1. IfCm = 1, we generatedAm|L¯(o)m , C¯m, A¯(o)m−1
from logistic regression logit−1 (Lm − 0.5Cm−1 − 0.5Am−1), else if Cm = 0, let Am = Am−1, follow-
ing assumption (4.2) and (4.3). For k = 1, ...,K, we generated the conditional mean of outcome
based on
E(Yk|l¯k−1, c¯k−1, a¯k−1) = 0 +
k−1∑
m=0
2 · [Lm − (0.5Lm−1 + 0.3Am−1)] + ψ1
k−1∑
m=0
Am,
where ψ1 = 1. This formulation is consistent with the ignorable treatment assumption (4.3) and the
ignorable missingness assumption (4.9). We generated the random error |l¯k−1, c¯k−1, a¯k−1 from
normal distributionN(0, 1), and then generated the observed outcome by Yk = E(Yk|l¯k−1, c¯k−1, a¯k−1)+
.
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Results
The simulation and estimation procedures were repeated 1000 times to give average estimates
(EST), empirical standard errors (SE), average asymptotic standard errors (ASE) and 95% coverage
probability. The results are shown in Table 4.2. The estimators from unweighted estimating equation
(4.13) (No IPW) are biased, although they have the smallest standard errors. The estimators from
inverse probability weighted estimating equation (4.10) with unstabilized and stabilized IPWs are
consistent. The standard errors for the estimators from using unstabilized weights may become
very large due to a few outliers, even though the 95% coverage probability is not much affected.
Therefore, it is highly recommended to use stabilized weights, especially in the presence of a
large number of time points. Theoretically speaking, the estimators from the monotone censoring
approach (4.14) are also consistent, but some bias is seen even in the estimators from using
stabilized weights due to a few outliers. In the monotone censoring approach, a large proportion
of the data is artificially censored at later time points. Weights for these estimators may become
very large and unstable at later time points. The stabilized IPW estimators from our approach
are more efficient than the stabilized monotone IPW estimators and have less small sample bias.
Surprisingly, increase in the number of time points from 5 to 7 did not result in more efficient
estimators in the all approaches. The efficiency of the estimators from our approach as well as
the monotone censoring approach were greatly affected by the proportion of missing data, mainly
because the chance of seeing estimate outliers is much higher in the presence of more missing data
(results not shown). To avoid the big influence of outliers on the estimates and asymptotic standard
errors, we suggest truncating inverse probability weights at a certain large value. Previous studies
have used truncation of weights to achieve balance between bias and efficiency [2][29]. In this
example, truncation of weights at 200 did not cause much bias, but greatly alleviate the influence
of outliers (Table 4.3).
4.5. Analysis of MAPP data
We apply our weighted SNMMs for intermittent missingness to data from the MAPP Research
Network. This research network was established by the National Institute of Diabetes and Digestive
and Kidney Diseases (NIDDK) of the U.S. National Institutes of Health (NIH) to better understand
the pathophysiology of urologic chronic pelvic pain [8]. This study included 424 patients, including
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Table 4.2: Results for the example with intermittent missingness in covariates and out-
come. Average estimates (EST), empirical standard errors (SE), average asymptotic standard
errors (ASE) and 95% coverage probability are listed for unweighted estimating equation (No IPW),
our approach with unstabilized (IPW) or stabilized (Stabilized IPW) weights, monotone censoring
approach with unstabilized (Monotone IPW) or stabilized (Monotone stabilized IPW) weights with
K = 5 or K = 7.
K=5 K=7
TRUE EST SE ASE 95%COV EST SE ASE
95%
COV
No IPW 1.00 1.18 0.09 0.11 0.617 1.14 0.09 0.10 0.741
IPW 1.00 1.02 0.30 0.28 0.937 1.02 13.03 77.36 0.933
Stabilized IPW 1.00 1.01 0.23 0.21 0.952 1.00 0.36 0.25 0.951
Monotone IPW 1.00 0.81 7.10 1.29 0.961 -2.22 112.71 6.72 0.971
Monotone stabilized IPW 1.00 0.97 0.73 0.43 0.953 1.06 1.98 0.54 0.960
Table 4.3: Results for the example with intermittent missingness in covariates and outcome,
in which if weights are greater than 200, they are truncated at 200.
K=5 K=7
TRUE EST SE AveSE
95%
COV EST SE
Ave
SE
95%
COV
No IPW 1.00 1.18 0.09 0.11 0.617 1.14 0.09 0.10 0.741
IPW 1.00 0.99 0.22 0.22 0.949 0.97 0.21 0.21 0.967
Stabilized IPW 1.00 1.01 0.23 0.21 0.952 1.00 0.26 0.22 0.952
Monotone IPW 1.00 0.77 1.65 0.73 0.960 1.02 9.78 1.61 0.968
Monotone stabilized IPW 1.00 0.97 0.74 0.43 0.953 0.94 3.19 0.59 0.960
191 males and 233 females, who were made eligible by reporting a nonzero response for the pelvic
pain scale.
The goal of the analysis is to evaluate the effect of NSAIDS on patients’ genitourinary pain index
(GUPI-pain), a measurement of pelvic pain. The treatment NSAIDS (medN) and a time-varying
covariate pain location (PP-only) were measured every two months, and GUPI-pain was measured
every two weeks up to 1 year. The patients could have been taking other treatments, such as
physical therapy (medP) and tricyclics (medT). For this analysis, we used the bimonthly time points.
There was intermittent missingness in both treatment and time-varying covariates. We excluded 32
patients with missing baseline treatment. 391 patients were included in the final analysis. Among
these patients, only 143 had complete measurement of the outcome GUPI-pain. There were 701
out of 2346 missing person-times for the outcome. We assume assumption (4.2) holds. Therefore,
last observation carried forward can be used to fill in the missing treatment. We also assume the
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ignorability assumptions (4.3) and (4.9) hold. The SNMM is simply
E
(
Y c¯;a¯m,0k |L¯m = l¯m, C¯m = c¯m, A¯m = a¯m
)
− E
(
Y
c¯;a¯m−1,0
k |L¯m = l¯m, C¯m = c¯m, A¯m = a¯m
)
=γ∗m,k (a¯m, c¯m;ψ) = ψ1am.
It assumes the effect of treatment is the same at each time and for all later outcomes. A consistent
estimator can be derived from estimating equation (4.10) with unstabilized or stabilized weights.
We fit a pooled logistic regression model for the treatment. It includes visit, treatment medN at the
previous visit, last observed PP-only, last observed GUPI-pain at the previous visit and medP in the
previous visit as predictors.
logitPr[Am = 1|L¯m, C¯m−1, A¯m−1, Cm = 1] =α0 + α1VISITm + α2medNm−1 + α3PP− only†m+
α4GUPI− pain†m−1 + α5medPm−1
We fit another pooled logistic regression model for the missingness indicator. It includes visit,
missingness indicator in the previous visit, treatment in the previous visit, the last observed gupis-
corepain, medT and medP at previous visit and baseline covariate age as predictors.
logitPr[Cm = 1|L¯m, C¯m−1, A¯m−1] =β0 + β1VISITm + β2Cm−1 + β3GUPI− pain†m + β4medTm−1+
β5medPm−1 + β6AGE.
We computed estimators from the unweighted estimating equation, the approach with weighting at
intermittent times and the monotone censoring approach with stabilized weights. Table 4.4 shows
the average estimate (EST), asymptotic standard error (SE) and p-value from these approaches.
Estimators from all the approaches are not significantly different from 0. The estimator from the
approach with weighting intermittent times is more efficient than that from the monotone censoring
approach. It also has the expected direction of effect (NSAID is expected to reduce pain). Based
on this analysis, NSAIDs are not effective in reducing genitourinary pain. However, the analysis is
complicated by the fact that the patients could have been taking other treatments and there was
lack of dose information.
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Table 4.4: Results from analyzing MAPP data
EST SE P-Value
No IPW -0.06 0.54 0.46
Stabilized IPW -0.15 0.57 0.39
Monotone stabilized IPW 0.06 0.72 0.47
4.6. Discussion
In this paper, we extended SNMMs to longitudinal observational data with intermittent missing ob-
servations. We presented two scenarios where the missingness indicator can be a confounder in
addition to other time-varying covariates and needs to be taken into consideration. We show that
the standard SNMMs can be used for situations where non-outcome covariates are missing inter-
mittently under the assumption of the last treatment carried forward. In situations where outcomes
are also missing intermittently, we used a method that does not require artificial censoring, but
requires a more strict MAR assumption.
Consistency of the estimators in our approach requires assumption (4.2) to hold. This is a plausible
assumption only under certain situations. In some cases, treatment does not hold constant during
missing times and are unknown to us. It is of interest to consider a different estimate that can
accommodate the missing treatment information. If assumption (4.2) does not hold, imputing the
missing treatment and confounder information may be a better choice. Methods that deal with
unmeasured confounding may also be considered. Like the conventional monotone censoring
approach, we use inverse probability weighting to control for selection bias in the presence of
missing outcomes. The estimators from the approach with weighting at intermittent times are more
efficient than those from the monotone censoring approach, because the approach with weighting
at intermittent times makes use of all observed time points. However, it requires a stricter MAR
assumption that states missingness can only depend on the observed history. The strict MAR
assumption may be violated in many cases. For instance, if less severe patients more likely miss
a prescheduled visit, missingness will depend on the patient’s covariates during the missing visits.
It is worthwhile to conduct sensitivity analysis for the MAR assumption. Even if the assumptions
we stated hold, we cannot obtain consistent estimation with the method introduced if there is effect
modification by time-varying covariates. We can either impute the missing time-varying covariates
or use last observation carried forward to fill in the missing time-varying covariates and conduct a
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sensitivity analysis.
We notice from our simulation study that in the presence of a large proportion of missing data,
the estimators in our approach and the monotone censoring approach can be influenced greatly
by very large weights, although this problem is less severe in our approach especially with the
use of stabilized weights. We suggest using truncation of weights to alleviate the problem. One
unexpected observation from simulation study is that the estimators do not become more efficient
with increased number of time points. This seems to be a general observation for SNMMs, and is
in contrast with other longitudinal data analysis methods. It is worthwhile to explore the underlying
reason.
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CHAPTER 5
DISCUSSION
In Chapter 2 and 3, we have extended two classes of causal models, SNMMs and MSMs, to clus-
tered observations in the presence of time-varying confounding. We formulate models that are
generalized to both cluster- and unit-level treatments, with consideration of interference, namely
the effect of treatment on outcomes in the other units of the same cluster. We also derive semi-
parametric estimators of parameters in those models. Our simulation study demonstrated that the
estimators are consistent and achieve reasonable efficiency in contrast to those from the conven-
tional GEE regression approach. If the causal model contains interference and treatments in units
within the same cluster are highly correlated, the estimators will perform poorly with large stan-
dard errors because of the multicollinearity problem. In situations like this, one may consider not
modeling the interference effect from other units. The MSM approach is easier to implement with
existing softwares in SAS and R. We explored the impact of IPWs and working correlation on the
efficiency of MSM estimators, and found that the use of unit-specific weights in the presence of no
interference and the use of non-independence working correlations in some cases may improve the
efficiency of MSM estimators.
We applied the methods in chapter 2 and 3 to a glaucoma trial dataset to compare the effectiveness
of two commonly used topical ocular hypertension medications in lowering IOP. In this study, two
eyes of a given subject formed a cluster, and subjects’ outcomes were measured repeatedly. At
each visit, different medications were not randomized in the treatment arm. Therefore, it is a setting
with clustered observations and time-varying confounding. We assumed a causal model with no
effect modification by time-varying covariates. Under these assumptions, the SNMMs and MSM
approaches are expected to give similar results. In both analyses, the effect of prostaglandin relative
to beta-blocker is not shown to be statistically significant. However, there is some contradiction in
the comparison between the combined treatment and the beta blocker: results from the SNMM
suggest the combined treatment is worse, whereas results from the MSM suggest the combined
treatment is more effective than the beta blocker. The former is counterintuitive. We expect the
combined treatment to be at least as good as either one of the single treatments. The discrepancy
may be partly due to mis-specification in the treatment model. These analyses were also subject
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to residual confounding, some of which was due to the lack of dose information for the treatments.
The impact of possible unmeasured confounding may be explored by sensitivity analyses.
In Chapter 4, we extend SNMMs to longitudinal observational data where subjects may miss
prescheduled visits intermittently and the missingness may depend on past covariate and treat-
ment history. In longitudinal studies, observation plans are often considered non-informative and
not taken into consideration in models for estimating the treatment effect. We consider two sce-
narios: 1) Intermittent missingness in the time-varying treatment and a final outcome with no miss-
ingness and 2) Intermittent missingness in the time-varying treatment and repeated outcome mea-
surements. We show that adherence to the observation schedule can be conceptualized as a
confounder in addition to other time-varying covariates. We show that under certain assumptions
the standard SNMMs can be used for situations where only non-outcome covariates are missing
intermittently. In situations where outcomes are also missing intermittently, selection bias due to the
missing outcomes needs to be controlled for. We used an IPW method that does not require artifi-
cial censoring, but requires a strict MAR assumption. Results from our simulation study show that
the estimators from the approach with weighting at intermittent times are consistent and achieve
higher efficiency compared to the monotone censoring approach. The former method is potentially
more useful when there are a large number of time points and a significant proportion of subjects
miss an early visit.
5.1. Future directions
5.1.1. Chapter 2 & 3
In Chapter 2, we have focused on continuous outcomes and an identity link in SNMMs. Our method
can potentially be generalized to discrete outcomes and other link functions. For binary outcomes
and the logit link, the causal parameter in SNMMs can be estimated by the approach proposed by
Vansteelandt and Goetghebeur (2003) [28]. The two-stage approach includes a structural model to
model causal effect and a traditional association model to model the mean of observed outcome in
the treatment arm. The causal model in their approach can be extended to clustered observations
in a similar way described in our method. The MSM approach introduced in Chapter 3 can be
directly applied to discrete outcomes and other link functions.
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In Chapter 2 and 3, we focused on examples with two units per cluster. It is interesting to explore
the performance of the estimators under larger cluster sizes, especially in the presence of interfer-
ence. The symmetry assumption is more important in such cases for reducing the dimension of
parameters. One may also consider cases where the cluster size varies between clusters in the
study population. In Chapter 2 and 3, we introduced methods for clustered outcomes of the same
type. In a more general situation, the correlated outcomes in a cluster can be of different types, for
instance, continuous versus discrete. It is more difficult to model correlation between variables from
two different distributions. We consider using copula [23] and structural nested distribution models
(SNDM) for this more complicated case.
In Chapter 3, we explored the impact of different between-units and between-times working corre-
lations on the efficiency of MSM estimator. The existing software in SAS (PROC GENMOD) does
not allow implementing a two-level correlation structure. If one of the two levels is independence
working correlation, PROC GENMOD can still be used to compute the estimators by treating the
non-independence level as a cluster. The sandwich estimators of standard errors need to be com-
puted manually using estimates for the mean and correlation parameters from SAS output. Shults
et al. (2004) has presented an approach to adjust for multiple sources of correlation in the frame-
work of GEE [22]. Shults and Ratcliffe (2007) implemented the approach for quasi least squares, an
approach in the framework of GEE [21]. It is worthwhile to also implement the multi-level working
correlation in GEE, so that it can be used for our method conveniently under various conditions.
5.1.2. Chapter 4
Consistency of the estimators in our approach requires a few assumptions to hold. It is worthwhile
to conduct sensitivity analysis for these assumptions or use alternative approaches when some of
the assumptions do not seem to hold. Firstly, we need to assume treatment follows last observation
carried forward during missing observations (4.2). This is a plausible assumption only under certain
situations. In some cases, treatment does not hold constant during missing times and are therefore
unknown. In other cases, treatment may be reported by the patients in the next visit but depends on
unknown covariates during the missing observations such that the ignorable treatment assumption
(4.3) is violated. Under these situations, imputing the missing covariates and treatments from their
conditional distributions can be a preferred approach. The imputation approach requires the usual
MAR assumption as well as correct specification of the distributions of the missing variables. It is
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of interest to examine how the imputation approach work under various conditions.
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APPENDIX A
CHAPTER 2 APPENDICES
A.1. Asymptotic variance estimator
We adapted the approach for calculating asymptotic variance of ψˆ from Robins (1992) [11]. Let α
denote nuisance parameters in the treatment model, Sα the score for α, Sψ the score for ψ, α0
and ψ0 the true parameters for α and ψ, S(α,ψ) = (STα , STψ )
T , Sα,i and Sψ,i the scores for sub-
ject i, Si = (STα,i, S
T
ψ,i)
T . Since Sψ is the score from a semiparametric model, n−
1
2Sψ
∣∣
ψ=ψ0
is
asymptotically normal with mean 0 and asymptotic variance I(ψ0) = E
(
Sψ,iS
T
ψ,i
∣∣
ψ=ψ0
)
. If α in the
treatment model is known, I(ψ0) can be consistently estimated by Iˆ(ψˆ) = 1n
∑n
i Sψ,iS
T
ψ,i
∣∣
ψ=ψˆ
. If α
needs to be estimated, we first calculate Iˆ(αˆ, ψˆ) =
Iˆαα Iˆαψ
Iˆψα Iˆψψ
 = 1n∑ni SiSTi |α=αˆ,ψ=ψˆ. By Tay-
lor’s expansion and Sluskey’s theorem, I(ψ0) is consistently estimated by Iˆ(ψˆ) = Iˆψψ− IˆψαIˆ−1αα Iˆαψ.
Again by Taylor’s expansion, n
1
2 (ψˆ − ψ0) will be asymptotically normal with mean 0 and asymp-
totic variance nB−1I(ψ0)B−1 which will be consistently estimated by nBˆ−1Iˆ(ψˆ)Bˆ−1, where B−1 =
E
(
∂Sψ,i
∂ψT
∣∣
α=α0,ψ=ψ0
)
, Bˆ−1 = n−1 ∂Sψ
∂ψT
∣∣
α=αˆ,ψ=ψˆ
.
A.2. Likelihood of SNMMs for clustered observations
For a single time point example, if we assume ignorable treatment, likelihood of a SNMM can be
written as the following:
g {E(Y|l0,a0)} = γ∗(l0,a0) +
[
g
{
E(Y0|l0)
}− g {E(Y0)}]+ g {E(Y0)}
= γ∗(l0,a0) + g
{
E(Y0|l0)
}
 = Y − E(Y|L0,A0)
f(O; ρ) = f((ρ)|L0,A0; η1) · f(L0; η2) · f(A0|L0; η3),
where O = (Y,L0,A0) represents observed data, ω represents nuisance parameters in the model
for E(Y0|l0), ρ = ψ × η × ω represents the parameter space.
The above example can be extended to time-varying treatments where treatments and covariates
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are measured repeatedly at times 0 to K − 1. Outcome is measured only at the last time point K.
First define
v∗m
(¯
lm, a¯m−1
)
= g
{
E
(
Ya¯m−1,0 |¯lm, a¯m−1
)}− g {E (Ya¯m−1,0 |¯lm−1, lm = 0, a¯m−1)}
Γ∗m
(¯
lm−1, a¯m−1
)
= g
∫
g−1
{
v∗m
(¯
lm, a¯m−1
)}
dF
(
lm |¯lm−1, a¯m−1
)
= −g {E (Ya¯m−1,0 |¯lm−1, lm = 0, a¯m−1)}+ g {E (Ya¯m−1,0 |¯lm−1, a¯m−1)}
The functions v∗m and Γ∗m are related to the association between covariates Lm and counterfactual
outcomes Ya¯m−1,0. Likelihood of a SNMM with identity or log link can be written as the following:
g
[
E(Y|¯lK−1, a¯K−1)
]
=
K−1∑
m=0
γ∗m(¯lm, a¯m) +
K−1∑
m=1
{
v∗m
(¯
lm, a¯m−1
)− Γ∗m (¯lm−1, a¯m−1)}+ g {E(Y0|l0)}
 =Y − E(Y|L¯K−1, A¯K−1)
f(O; ρ) =f((ρ)|L¯K−1, A¯K−1; η1) ·
K−1∏
k=0
f(Lk|L¯k−1, A¯k−1; η2) · f(Ak|L¯k, A¯k−1; η3),
where O = (Y, L¯K−1, A¯K−1) represents observed data, ω represents nuisance parameters in
the model for E(Y0|l0), µ represents nuisance parameters in the models for v∗m
(¯
lm, a¯m−1
)
, ρ =
ψ× η× µ× ω represents the parameter space. Choosing a linear working model for v∗m
(¯
lm, a¯m−1
)
will facilitate writing an analytical form for the full likelihood.
Lastly, the second example can be further generalized to repeatedly measured outcomes at times
k = 1, ...,K. Similarly, we define
v∗m,k
(¯
lm, a¯m−1
)
= g
{
E
(
Y
a¯m−1,0
k |¯lm,am−1
)}
− g
{
E
(
Y
a¯m−1,0
k |¯lm−1, lm = 0, a¯m−1
)}
Γ∗m,k
(¯
lm−1, a¯m−1
)
= −g
{
E
(
Y
a¯m−1,0
k |¯lm−1, lm = 0, a¯m−1
)}
+ g
{
E
(
Y
a¯m−1,0
k |¯lm−1, a¯m−1
)}
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Likelihood of a SNMM with identity or log link can be written as the following:
g
(
E(Yk |¯lk−1, a¯k−1)
)
=
k−1∑
m=0
γ∗m,k (¯lm, a¯m) +
k−1∑
m=1
{
v∗m,k
(¯
lm, a¯m−1
)− Γ∗m,k (¯lm−1, a¯m−1)}+ g {E(Y0k |l0)}
k =Yk − E(Yk|L¯k−1, A¯k−1)
f(O; ρ) =
K∏
k=1
f(k(ρ)|L¯k−1, A¯k−1; η1) ·
K−1∏
k=0
f(Vk|L¯k−1, A¯k−1,Yk; η2) · f(Ak|L¯k, A¯k−1; η3),
where Lk = (Vk,Yk), O = (Y¯K , L¯K−1, A¯K−1), ω represents nuisance parameters in the models
for E(Y0k |l0), µ represents nuisance parameters in the models for v∗m,k
(¯
lm, a¯m−1
)
, ρ = ψ×η×µ×ω
represents the parameter space.
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APPENDIX B
CHAPTER 3 APPENDICES
B.1. Proof of consistency of MSM estimator
B.1.1. part 1
For the estimating equation in (3.3), it is straightforward to show that
E
{∑
a
I(Ai = a) ·Wi ·HiV −1i (Yi − µ(a;ψ))
}
=
∑
a
E
{
I(Ai = a) ·Wi ·HiV −1i (Yai − µ(a;ψ))
}
=
∑
a
E
[
E
{
I(Ai = a)
f(a|Li) ·HiV
−1
i (Y
a
i − µ(a;ψ)) |Li
}]
=
∑
a
E
[
E
{
I(Ai = a)
f(a|Li)
∣∣∣Li} ·HiV −1i E {(Yai − µ(a;ψ)) |Li}] ∵ Ya ⊥ A|L
=
∑
a
E
[
HiV
−1
i E {(Yai − µ(a;ψ)) |Li}
]
=
∑
a
HiV
−1
i E {Yai − µ(a;ψ)}
=0.
The proves the consistency of the estimator for ψ in a point treatment setting.
B.1.2. part 2
MSM under no interference assumption can be written as
E(Y
aj ,aj′
j ) = µj(aj ;β),
where {j, j′} = {1, 2}, {2, 1}.
The estimating equation for this setting with unit-specific weights Wij can be written as
N∑
i=1
∑
a
I(Ai = a) ·HiW
1
2
i V
−1
i W
1
2
i i(ψ) = 0, (B.1)
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where
Wi =
Wi1 0
0 Wi2
 ,
and Wi1 and Wi2 are unit-specific weights for units j = 1 and 2 respectively.
Wij = P (Aij = aj |Li)−1 = f(aj |Li)−1
i(ψ) =
i1(ψ)
i2(ψ)
 =
Yi1 − µ1(a1;ψ)
Yi2 − µ2(a2;ψ)

Hi = {h1(a1), h2(a2)}
Vi = Vi(a) = σ
2
1 ρ
ρ 1

After doing some algebra, (B.1) can be simplified to
N∑
i=1
∑
a
I(Ai = a) · 1
σ2(1− ρ) ·
{
hi1Wi1i1 + hi2Wi2i2 − ρW
1
2
i1W
1
2
i2 (hi1i2 + hi2i1)
}
.
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It can be shown that
E
{∑
a
I(Ai = a) · hi1Wi1i1
}
=E
[∑
a1
∑
a2
I(Ai1 = a1, Ai2 = a2) · hi1Wi1 {Y a1i1 − µ1(a1;β)}
]
=E
[∑
a1
I(Ai1 = a1) · hi1Wi1 {Y a1i1 − µ1(a1;β)}
]
=
∑
a1
E (E [I(Ai1 = a1) · hi1Wi1 {Y a1i1 − µ1(a1;β)} |Li])
=
∑
a1
E
[
E
{
I(Ai1 = a1)
f(a1|Li)
∣∣∣Li} · hi1E {Y a1i1 − µ1(a1;β)|Li}] ∵ Y a11 ⊥ A1|L
=0
Similarly,
E
{∑
a
I(Ai = a) · hi2Wi2i2
}
= 0
However,
E
{∑
a
I(Ai = a) · ρW
1
2
i1W
1
2
i2 (hi1i2 + hi2i1)
}
= 0
if and only if ρ = 0. Therefore, when unit-specific weights are used between units in settings with
no interference, independence working correlation needs to be used so that the estimator for ψ is
consistent.
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B.1.3. part 3
For the estimating equation in (3.9), by doing sequential double expectation, it can be shown that
E
∑
a¯k−1
I(A¯i,k−1 = a¯k−1) ·Wik ·HikV −1ik
{
Y
a¯k−1
ik − µk(a¯k−1;β)
}
=
∑
a¯k−1
E
[
k−1∏
m=0
I(A¯im = a¯m) ·Wik ·HikV −1ik
{
Y
a¯k−1
ik − µk(a¯k−1;β)
}]
=
∑
a¯k−1
E
[
E
{
I(Ai,k−1 = ak−1)
f
(
ak−1|L¯i,k−1, A¯i,k−2 = a¯k−2
) ∣∣∣L¯i,k−1, A¯i,k−2 = a¯k−2} k−2∏
m=0
I(A¯im = a¯m)
f
(
am|L¯i,m, A¯i,m−1 = a¯m−1
) ·
HikV
−1
ik E
{
Y
a¯k−1
ik − µk(a¯k−1;β)|L¯i,k−1, A¯i,k−2 = a¯k−2
}]
∵ Ya¯k ⊥ Am|L¯m, A¯m−1, m < k
=
∑
a¯k−1
E
[
k−2∏
m=0
I(A¯im = a¯m)
f
(
am|L¯i,m, A¯i,m−1 = a¯m−1
) ·HikV −1ik E {Ya¯k−1ik − µk(a¯k−1;β)|L¯i,k−1, A¯i,k−2 = a¯k−2}
]
=
∑
a¯k−1
E
[
E
{
I(Ai,k−2 = ak−2)
f
(
ak−2|L¯i,k−2, A¯i,k−3 = a¯k−3
) ∣∣∣L¯i,k−2, A¯i,k−3 = a¯k−3} k−3∏
m=0
I(A¯im = a¯m)
f
(
am|L¯i,m, A¯i,m−1 = a¯m−1
) ·
HikV
−1
ik E
{
Y
a¯k−1
ik − µk(a¯k−1;β)|L¯i,k−2, A¯i,k−3 = a¯k−3
}]
∵ Ya¯k ⊥ Am|L¯m, A¯m−1, m < k
...
=0
The proves the consistency of the estimator for ψ in a time-varying treatment setting using cluster-
specific and time-specific weights.
B.2. Likelihood of MSM for clustered observations
Suppose that treatments, covariates are measured repeatedly at times m = 0, ...,K − 1, and out-
comes are measured repeatedly at times k = 1, ...,K. Let Lm = (Vm,Ym), where Vm represent
covariates that exclude outcomes at time m. Likelihood of a MSM can be partitioned as the follow-
ing:
f(O; ρ) =
K∏
k=1
f(k(ρ)|L¯K−1, A¯K−1; η1) ·
K−1∏
k=0
f(Lk|L¯k−1, A¯k−1; η2) · f(Ak|L¯k, A¯k−1; η3),
72
k = Y
a¯
k − E(Ya¯k |¯lk−1, a¯k−1),
where O = (Y, L¯K−1, A¯K−1) represents observed data, µ represents nuisance parameters in the
models for v∗m
(¯
lm, a¯m−1
)
, ρ = ψ × η × µ represents the parameter space.
The conditional mean of potential outcomes E(Ya¯k |¯lk−1, a¯k−1) is specified as the following:
g
{
E(Ya¯k |¯lk−1, a¯k−1)
}
=
k−1∑
m=0
g
{
E(Ya¯k |¯lm, a¯m)
}− g {E(Ya¯k |¯lm−1, a¯m)}+
g
{
E(Ya¯k |¯lm, a¯m−1)
}− g {E(Ya¯k |¯lm−1, a¯m−1)}+ g {E(Ya¯k |v0)} .
Under sequential ignorability assumption, Ya¯k ⊥ Am|L¯m, A¯m−1, for m < k. The above expression
can be simplified to:
g
{
E(Ya¯k |¯lk−1, a¯k−1)
}
=
k−1∑
m=0
g
{
E(Ya¯k |¯lm, a¯m−1)
}− g {E(Ya¯k |¯lm−1, a¯m−1)}+ g {E(Ya¯k |v0)}
=
k−1∑
m=0
{
v∗m
(¯
lm,k,a¯m−1
)− Γ∗m,k (¯lm−1, a¯m−1)}+ g {E(Ya¯k |v0)} ,
where
v∗m,k
(¯
lm, a¯m−1
)
= g
{
E
(
Ya¯k |¯lm, a¯m−1
)}− g {E (Ya¯k |¯lm−1, lm = 0, a¯m−1)} , for m > 0
v∗m,k
(¯
lm, a¯m−1
)
= g
{
E
(
Ya¯k |¯l0
)}− g {E (Ya¯k |v0, l0\v0 = 0)} , for m = 0
Γ∗m,k
(¯
lm−1, a¯m−1
)
= g
∫
g−1
{
v∗m
(¯
lm, a¯m−1
)}
dF
(
lm |¯lm−1, a¯m−1
)
= −g {E (Ya¯k |¯lm−1, lm = 0, a¯m−1)}+ g {E (Ya¯k |¯lm−1, a¯m−1)} , for m > 0
Γ∗m,k
(¯
lm−1, a¯m−1
)
= −g {E (Ya¯k |v0, l0\v0 = 0)}+ g {E (Ya¯k |v¯0)} , for m = 0
L0\V0 refer to those components of L0 other than baseline covariates V0. The functions v∗m and
Γ∗m are related to the association between covariates Lm and potential outcomes Ya¯.
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B.3. Results from a different simulation example
Compared to the previous example, in this simulation example, the coefficient of cluster-specific
covariate l†m in the conditional mean of the potential outcome was increased in magnitude to make
the association between l†m and outcomes stronger. For the example with interference,
E(Ya¯k |¯lk−1, a¯k−1) =
k−1∑
m=0

lm,1 − 2 l†m
lm,2 − 2 l†m
− E

lm,1 − 2 l†m
lm,2 − 2 l†m
 |¯lm−1, a¯m−1

+ψ0 + ψ1∑k−1m=0 am,1 + ψ2∑k−1m=0 am,2 + ψ3∑k−1m=0 am,1am,2
ψ0 + ψ1
∑k−1
m=0 am,2 + ψ2
∑k−1
m=0 am,1 + ψ3
∑k−1
m=0 am,2am,1
 ,
where ψ0 = 0, ψ1 = 2, ψ2 = 1, ψ3 = 0.5. For the example with no interference,
E(Ya¯k |¯lk−1, a¯k−1) =
k−1∑
m=0

lm,1 − 2 l†m
lm,2 − 2 l†m
− E

lm,1 − 2 l†m
lm,2 − 2 l†m
 |¯lm−1, a¯m−1

+
ψ0 + ψ1∑k−1m=0 am,1
ψ0 + ψ1
∑k−1
m=0 am,2
 ,
where ψ0 = 0, ψ1 = 2. The results from this example are shown in Table (B.1) and (B.2).
Table B.1: Compare estimators from MSM with different working correlations for the example
with interference. Sample size N=1000. ψ0 represents the intercept, ψ1 represents the effect of
treatment on the same unit, ψ2 represents the effect of treatment on the opposite unit, ψ3 represents
interaction between treatments. The true values of parameters are ψ0 = 0, ψ1 = 2, ψ2 = 1, ψ3 = 0.5.
The weights used are cluster-specific. The weights used for AR(1) between times correlation are
also time-fixed.
Independent Exchangeablebetween units
AR(1)
between times
Unstabilized Stabilized Unstabilized Stabilized Unstabilized Stabilized
Param Bias SE Bias SE Bias SE Bias SE Bias SE Bias SE
ψ0 -0.07 0.56 -0.01 0.23 -0.07 0.56 -0.01 0.23 -0.01 0.20 -0.01 0.19
ψ1 0.03 0.26 0.01 0.14 0.03 0.26 0.01 0.14 0.01 0.13 0.01 0.11
ψ2 0.03 0.25 0.01 0.14 0.03 0.25 0.01 0.14 0.01 0.13 0.01 0.11
ψ3 -0.02 0.43 -0.01 0.27 -0.02 0.43 -0.01 0.27 -0.00 0.28 -0.00 0.24
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Table B.2: Compare estimators from MSM with different working correlations for the example
with no interference. Sample size N=1000. ψ0 represents the intercept, ψ1 represents the effect
of treatment on the same unit. The true values of parameters are ψ0 = 0, ψ1 = 2. Both cluster-
specific and unit-specific weights are used. The weights used for AR(1) between times correlation
are time-fixed.
Independent Exchangeablebetween units
AR(1)
between times
Unstabilized Stabilized Unstabilized Stabilized Unstabilized Stabilized
Param Bias SE Bias SE Bias SE Bias SE Bias SE Bias SE
Cluster-specific ψ0 -0.02 0.35 -0.00 0.17 -0.00 0.25 0.00 0.14 -0.01 0.18 -0.01 0.18
ψ1 0.02 0.18 0.01 0.12 0.01 0.08 0.00 0.06 0.01 0.11 0.01 0.11
Unit-specific ψ0 0.00 0.14 0.02 0.11 0.42 0.17 0.27 0.13 0.00 0.10 0.01 0.10
ψ1 0.00 0.08 -0.02 0.07 -0.29 0.08 -0.27 0.07 0.00 0.07 -0.01 0.07
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APPENDIX C
CHAPTER 4 APPENDICES
C.1. Likelihood of SNMM with random observation times
Suppose covariates and treatments are measured repeatedly among random observation times
∈ (0, 1, ...,K− 1), and outcomes are measured only at a fixed last follow-up time K with no missing
observation. The complete data likelihood of a SNMM with identity or log link can be partitioned as
the following:
f(O; ρ) =
K∏
k=1
f(k(ρ)|L¯K−1, A¯K−1; η1) ·
K−1∏
k=0
f(Lk|L¯k−1, C¯k−1, A¯k−1; η2) · f(Ck|L¯k, C¯k−1, A¯k−1; η3)·
f(Ak|L¯k, C¯k, A¯k−1; η4),
k =Yk − E(Yk|L¯K−1, C¯K−1, A¯K−1),
where O = (Y¯K , L¯K−1, A¯K−1) represents observed data, ω represents nuisance parameters in
the model for E(Y 0k ), µ represents nuisance parameters in the models for v
†
m
(
l¯m, c¯m, a¯m−1
)
and
v∗m
(
l¯m, c¯m−1, a¯m−1
)
, ρ = ψ × η × µ× ω represents the parameter space.
The conditional mean of observed outcomes is specified as the following:
g
[
E(Y c¯,a¯k |¯lK−1, c¯K−1, a¯K−1)
]
=g
{
E(Y 0k )
}
+
K−1∑
m=0
{
v∗m
(
l¯m, c¯m−1, a¯m−1
)− Γ∗m (l¯m−1, c¯m−1, a¯m−1)}+
{
qm
(
l¯m, c¯m, a¯a
)− Γm (l¯m, c¯m, a¯m−1)}+ {q†m (l¯m, c¯m, a¯m−1)− Γ†m (l¯m, c¯m−1, a¯m−1)}
γ∗m(l¯m, c¯m, a¯m),
where
γ∗m(l¯m, c¯m, a¯m) = g
[
E(Y c¯m,0;a¯m,0k |l¯m, c¯m, a¯m)
]
− g
[
E(Y
c¯m−1,0;a¯m−1,0
k |l¯m, c¯m, a¯m)
]
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is the blip function containing the causal parameter of interest ψ.
v∗m
(
l¯m, c¯m−1, a¯m−1
)
= g
[
E(Y
c¯m−1,0;a¯m−1,0
k |l¯m, c¯m−1, a¯m−1)
]
− g
[
E(Y
c¯m−1,0;a¯m−1,0
k |l¯m−1, c¯m−1, a¯m−1, lm = 0)
]
Γ∗m
(¯
lm−1, a¯m−1
)
= g
∫
g−1
{
v∗m
(
l¯m, c¯m−1, a¯m−1
)}
dF
(
lm|l¯m−1, c¯m−1, a¯m−1
)
=− g
[
E
(
Y
c¯m−1,0;a¯m−1,0
k |l¯m−1, c¯m−1, a¯m−1, lm = 0
)]
+ g
[
E
(
Y
c¯m−1,0;a¯m−1,0
k |l¯m−1, c¯m−1, a¯m−1
)]
are related to the association between covariates Lm and potential outcome Y
a¯m−1,0
k . Choosing lin-
ear working model for v∗m
(
l¯m, c¯m−1, a¯m−1
)
will facilitate writing an analytical form for the likelihood.
qm
(
l¯m, c¯m, a¯m
)
=g
[
E
(
Y
c¯m−1,0;a¯m−1,0
k |l¯m, c¯m, a¯m)
]
− g
[
E(Y
c¯m−1,0;a¯m−1,0
k |l¯m, c¯m, a¯m−1, am = 0
)]
Γm
(
l¯m, c¯m, a¯m−1
)
=− g
[
E
(
Y
c¯m−1,0;a¯m−1,0
k |l¯m, c¯m, a¯m−1, am = 0
)]
+ g
[
E
(
Y
c¯m−1,0;a¯m−1,0
k |l¯m, c¯m, a¯m−1
)]
as well as
q†m
(
l¯m, c¯m, a¯m−1
)
=g
[
E
(
Y
c¯m−1,0;a¯m−1,0
k |l¯m, c¯m, a¯m−1)
]
− g
[
E(Y
c¯m−1,0;a¯m−1,0
k |l¯m, c¯m−1, cm = 0, a¯m−1
)]
Γ†m
(
l¯m, c¯m−1, a¯m−1
)
=− g
[
E
(
Y
c¯m−1,0;a¯m−1,0
k |l¯m, c¯m−1, cm = 0, a¯m−1
)]
+ g
[
E
(
Y c¯m−1,0;a¯m−1,0|l¯m, c¯m−1, a¯m−1
)]
are related to unmeasured confounding to treatment am and missing indicator cm respectively.
Under ignorable assumptions (4.3) and (4.9), both terms equal 0. They can be used to conduct
sensitivity analysis.
C.2. Proof of consistency of estimator
Estimating equation (4.10) can be rewritten as
N∑
i=1
K−1∑
m=0
K∑
k=m+1
[
h
(
L¯
(o)
im, C¯im, A¯im
)
− E
{
h
(
L¯
(o)
im, C¯im, A¯im
)
|L¯(o)im, C¯im, A¯i,m−1
}]
·
{
Yik −
k−1∑
l=m
γ∗l,k
(
C¯il, A¯il;ψ
)} ·
k∏
l=m+1
I(Cil = cil)P
(
Cil = cil|L¯(o)il , C¯i,l−1, A¯i,l−1
)−1
= 0,
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where h
(
L¯
(o)
im, C¯im, A¯im
)
is an arbitrary function of
{
L¯
(o)
im, C¯im, A¯im
}
, I(Cil = cil) is an indicator
function that equals 1 if the missingness equals the observed missingness and 0 otherwise.
E
(
K−1∑
m=0
K∑
k=m+1
[
h
(
L¯
(o)
im, C¯im, A¯im
)
− E
{
h
(
L¯
(o)
im, C¯im, A¯im
)
|L¯(o)im, C¯im, A¯i,m−1
}]
·
{
Yik −
k−1∑
l=m
γ∗l,k
(
C¯il, A¯l;ψ
)} ·
k∏
l=m+1
I(Cil = cil)P
(
Cil = cil|L¯(o)il , C¯i,l−1, A¯i,l−1
)−1)
=
K−1∑
m=0
K∑
k=m+1
E
([
h
(
L¯
(o)
im, C¯im, A¯im
)
− E
{
h
(
L¯
(o)
im, C¯im, A¯im
)
|L¯(o)im, C¯im, A¯i,m−1
}]
·
E
{
Yik −
k−1∑
l=m
γ∗l,k
(
C¯il, A¯l;ψ
) |L¯(o)ik , C¯i,k−1, A¯i,k−1
}
·
k−1∏
l=m+1
I(Cil = cil)P
(
Cil = cil|L¯(o)il , C¯i,l−1, A¯i,l−1
)−1
·
E
(
Ck = ck|L¯(o)ik , C¯i,k−1, A¯i,k−1
)
P
(
Ck = ck|L¯(o)ik , C¯i,k−1, A¯i,k−1
)−1)
=
K−1∑
m=0
K∑
k=m+1
E
([
h
(
L¯
(o)
im, C¯im, A¯im
)
− E
{
h
(
L¯
(o)
im, C¯im, A¯im
)
|L¯(o)im, C¯im, A¯i,m−1
}]
·
E
{
Yik −
k−1∑
l=m
γ∗l,k
(
C¯il, A¯l;ψ
) |L¯(o)ik , C¯i,k−1, A¯i,k−1
}
·
k−1∏
l=m+1
I(Cil = cil)P
(
Cil = cil|L¯(o)il , C¯i,l−1, A¯i,l−1
)−1)
=...
=
K−1∑
m=0
K∑
k=m+1
E
([
h
(
L¯
(o)
im, C¯im, A¯im
)
− E
{
h
(
L¯
(o)
im, C¯im, A¯im
)
|L¯(o)im, C¯im, A¯i,m−1
}]
·
E
{
Yik −
k−1∑
l=m
γ∗l,k
(
C¯il, A¯il;ψ
) |L¯(o)im, C¯i,m−1, A¯i,m−1
})
=
K−1∑
m=0
K∑
k=m+1
E
([
h
(
L¯
(o)
im, C¯im, A¯im
)
− E
{
h
(
L¯
(o)
im, C¯im, A¯im
)
|L¯(o)im, C¯im, A¯i,m−1
}]
·
E
{
Yik −
k−1∑
l=m
γ∗l,k
(
C¯il, A¯il;ψ
) |L¯(o)im, C¯im, A¯i,m−1
})
=0
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